var data={"specialtyName":"Authors and Editors in Allergy and Immunology","contributorTypes":[{"name":"Editors-in-Chief","contributors":[{"name":"Bruce S Bochner, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Adult Allergy; Asthma\n","Samuel M Feinberg Professor of Medicine \n","Northwestern University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIAID; NHLBI, Acerta Pharma [Siglec-6, Siglec-8, Siglec-9, asthma, COPD, anaphylaxis, imaging, eosinophilic granulomatosis with polyangiitis, food allergy, Bruton's tyrosine kinase, mastocytosis]. Consultant/Advisory Boards: GSK; AstraZeneca; TEVA; Genentech; Allakos [Eosinophil and mast cell-related disease (Mepolizumab, reslizumab, benralizumab)]. Patent Holder: Siglec-8 and its ligand; anti-Siglec-8 antibodies [Eosinophil and mast cell-associated disease (AK002 [in clinical trials; not yet FDA-approved])]. Equity Ownership/Stock Options: Allakos [Eosinophil and mast cell-associated diseases (AK002 [in clinical trials; not yet FDA-approved])]. Other Financial Interest: Elsevier [Publication royalties (Allergy and Immunology)]."},{"name":"E Richard Stiehm, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Immunology and Immunodeficiency\n","Distinguished Research Professor of Pediatrics\n","David Geffen School of Medicine at UCLA"],"disclosure":"Consultant/Advisory Boards: ADMA Biologics [Infections of respiratory syncytial virus in organ transplants (Respiratory syncytial virus immune globulin)]."},{"name":"Robert A Wood, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Pediatric Allergy\n","Professor of Pediatrics\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: DBV Technologies; Aimmune; Astellas; HAL-Allergy [Food allergy]."}]},{"name":"Deputy Editors","contributors":[{"name":"Anna M Feldweg, MD","credentials":["Director, Editorial Management — UpToDate\n","Deputy Editor — Allergy and Immunology\n","Assistant Professor of Medicine, Part-time\n","Harvard Medical School"],"disclosure":""},{"name":"Elizabeth TePas, MD, MS","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Allergy and Immunology\n","Deputy Editor — Pediatrics\n","Instructor in Medicine\n","Harvard Medical School"],"disclosure":""}]},{"name":"Section Editors","contributors":[{"name":"N Franklin Adkinson, Jr, MD","credentials":["Section Editor — Drug Allergy\n","Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Consultant/Advisory Boards: ViiV Healthcare; Amgen; Merck; Boehringer Ingelheim [Hypersensitivity reactions and anaphylaxis in drugs under development (Fluoroquinolones)]; Pfizer; Alexion; aTyr Pharma; Genzyme/Sanofi; Synageva [DSMB for drug products under development]; Merck [Allergen immunotherapy products (Oral tablets for allergen immunotherapy)]; DBV Technologies [Epicutaneous immunotherapy products]. Equity Ownership/Stock Options: AllerQuest [Penicillin allergy diagnosis (Penicilloyl polylysine)]; DBV Technologies [Epicutaneous immunotherapy (Viaskin patches)]."},{"name":"Bruce S Bochner, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Adult Allergy; Asthma\n","Samuel M Feinberg Professor of Medicine \n","Northwestern University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIAID; NHLBI, Acerta Pharma [Siglec-6, Siglec-8, Siglec-9, asthma, COPD, anaphylaxis, imaging, eosinophilic granulomatosis with polyangiitis, food allergy, Bruton's tyrosine kinase, mastocytosis]. Consultant/Advisory Boards: GSK; AstraZeneca; TEVA; Genentech; Allakos [Eosinophil and mast cell-related disease (Mepolizumab, reslizumab, benralizumab)]. Patent Holder: Siglec-8 and its ligand; anti-Siglec-8 antibodies [Eosinophil and mast cell-associated disease (AK002 [in clinical trials; not yet FDA-approved])]. Equity Ownership/Stock Options: Allakos [Eosinophil and mast cell-associated diseases (AK002 [in clinical trials; not yet FDA-approved])]. Other Financial Interest: Elsevier [Publication royalties (Allergy and Immunology)]."},{"name":"Francisco A Bonilla, MD, PhD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Associate Professor of Pediatrics\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Charles River Associates International (Germany) GmbH [Consultant(Genetics of immunodeficiency)]; Grand Rounds Health [Consultant(Patient care)]; Green Cross, Parexel [DSM(Immunoglobulin therapy)]; Guidepoint Global Advisors [Consultant(General immunodeficiency)]; Health Resources Services Administration/HHS [Consultant(Vaccine injury)]; Immune Deficiency Foundation [Consultant(Patient care / Advisory board)]; Louis August Jonas Foundation [Board Member]; Sarepta [Consultant(Biologic therapy)]."},{"name":"Jonathan Corren, MD","credentials":["Section Editor — Rhinitis and Sinusitis\n","Associate Clinical Professor of Medicine\n","David Geffen School of Medicine at UCLA"],"disclosure":"Grant/Research/Clinical Trial Support: Stallergenes Greer [Sublingual immunotherapy trial]; Regeneron Pharmaceuticals [Pilot study of grass nasal allergen challenge]."},{"name":"Peter S Creticos, MD","credentials":["Section Editor — Immunotherapy\n","Associate Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Stallergenes-Greer [Immunotherapy (SLIT)]; Circassia [Immunotherapy (Peptides)]. Consultant/Advisory Boards: Circassia; Greer; ITI [Immunotherapy (SCIT; SLIT)]; Allakos [Cytokine antagonists]; ASIT [AIT]."},{"name":"Helen V Firth, DM, FRCP, DCH","credentials":["Section Editor — Genetics\n","Consultant Clinical Geneticist\n","Addenbrooke's Hospital, Cambridge, UK"],"disclosure":""},{"name":"David B Golden, MD","credentials":["Section Editor — Bites and Stings\n","Associate Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Asthma (Omalizumab)]. Speaker's Bureau: Genentech [Asthma (Omalizumab)]; Stallergenes/Greer [Allergic rhinitis (Sweet vernal, orchard, perennial rye, Timothy, and Kentucky blue grass mixed pollens allergen extract)]."},{"name":"Sihoun Hahn, MD, PhD","credentials":["Section Editor — Genetics\n","Professor of Pediatrics\n","University of Washington School of Medicine, Seattle Children's Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Genzyme [Pompe disease, registry study (Alglucosidase alpha)]; Alexion [Hypophosphatasia (Asfotase alpha)]; Shire [Hunter disease (Idursulfase)]; BioMarin [Registry study]; Shire [Registry study]; Wilson Therapeutics AB [Wilson disease (WTX 101-203-301 study)]; Genzyme [Pompe disease, ADVANCE (Alglucosidase alfa)]."},{"name":"John M Kelso, MD","credentials":["Section Editor – Anaphylaxis\n","Division of Allergy, Asthma, and Immunology\n","Scripps Clinic, San Diego, CA"],"disclosure":""},{"name":"Marisa Klein-Gitelman, MD, MPH","credentials":["Section Editor — Pediatric Rheumatology\n","Chief, Division of Rheumatology\n","Ann & Robert H. Lurie Children's Hospital of Chicago\n","Professor of Pediatrics\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"Luigi D Notarangelo, MD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Bethesda, MD"],"disclosure":""},{"name":"Jordan S Orange, MD, PhD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Professor of Pediatrics\n","Chief of Immunology, Allergy, and Rheumatology\n","Baylor College of Medicine\n","Texas Children's Hospital"],"disclosure":"Consultant/Advisory Boards: ADMA Biologics; Shire; CSL Behring; Grifols [Primary immunodeficiency (IVIG, SCIG)]."},{"name":"Jennifer M Puck, MD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Professor of Pediatrics\n","University of California, San Francisco"],"disclosure":"Consultant/Advisory Boards (spouse): Pfizer [Rare diseases]. Employment (spouse): Invitae [Gene sequencing]. Equity Ownership/Stock Options (spouse): Invitae [Gene sequencing]."},{"name":"Sarbjit Saini, MD","credentials":["Section Editor — Urticaria and Angioedema\n","Associate Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Asthma, urticaria (Omalizumab)]; AstraZeneca [Asthma, urticaria (Omalizumab)]. Consultant/Advisory Boards: Genentech [Urticaria (Omalizumab)]; Medimmune [Urticaria (Omalizumab)]."},{"name":"Scott H Sicherer, MD, FAAAAI","credentials":["Section Editor — Food Allergy\n","Professor of Pediatrics\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: HAL Allergy [Food allergy]; Food Allergy Research and Education [Food allergy]; NIAID [Food allergy clinical trials]. Consultant/Advisory Boards: International Association for FPIES [FPIES]."},{"name":"E Richard Stiehm, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Immunology and Immunodeficiency\n","Distinguished Research Professor of Pediatrics\n","David Geffen School of Medicine at UCLA"],"disclosure":"Consultant/Advisory Boards: ADMA Biologics [Infections of respiratory syncytial virus in organ transplants (Respiratory syncytial virus immune globulin)]."},{"name":"Robert Sundel, MD","credentials":["Section Editor — Pediatric Rheumatology\n","Associate Professor of Pediatrics\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Juvenile idiopathic arthritis (Tofacitinib)]. Other Financial Interest: Expert consultant in patent case involving application for biosimilar status of an anti-TNF agent."},{"name":"Robert A Wood, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Pediatric Allergy\n","Professor of Pediatrics\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: DBV Technologies; Aimmune; Astellas; HAL-Allergy [Food allergy]."}]},{"name":"Editorial Assistants","contributors":[{"name":"Aisling D Francoeur, BA","credentials":["Senior Development Editor — UpToDate"],"disclosure":""},{"name":"Elizabeth Packer, MA","credentials":["Development Editor — UpToDate"],"disclosure":""}]},{"name":"Authors","contributors":[{"name":"Judith A Aberg, MD","credentials":["Chief, Division of Infectious Diseases\n","George Baehr Professor of Medicine\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: GSK [HIV investigational study on attachment inhibitor (GSK 663068)]; Gilead [HIV (Tenofovir alenfenamide)]; GSK [Long acting injectables (Cabotegravir, rilpivirine)]. Consultant/Advisory Boards: Gilead [HIV (TDF)]; Janssen [HIV (Darunavir)]; Merck [HIV (Raltegravir)]; Viiv [HIV [ABC, 3TC, DTG)]."},{"name":"Loutfi Sami Aboussouan, MD","credentials":["Staff\n","Cleveland Clinic Foundation"],"disclosure":""},{"name":"Clara Abraham, MD","credentials":["Associate Professor of Medicine\n","Yale University"],"disclosure":""},{"name":"Vikki M Abrahams, PhD","credentials":["Associate Professor \n","Yale University School of Medicine"],"disclosure":""},{"name":"Elaine J Abrams, MD","credentials":["Professor of Pediatrics and Epidemiology\n","Columbia University"],"disclosure":"Consultant/Advisory Boards: Viiv [Pediatric antiretroviral medications (Dolutegravir, maraviroc)]."},{"name":"Seema S Aceves, MD, PhD","credentials":["Associate Professor of Pediatrics and Medicine\n","University of California, San Diego\n","Rady Children's Hospital, San Diiego"],"disclosure":"Grant/Research/Clinical Trial Support: Ferring Research Institute [Eosinophilic esophagitis]. Consultant/Advisory Boards: Regeneron Pharma [Eosinophilic esophagitis (Dupilumab)]. Patent Holder: UCSD [Oral viscous budesonide licensed by Shire]."},{"name":"Ian M Adcock, FSB","credentials":["Professor of Cell & Molecular Biology, Airways Disease Section\n","National Heart and Lung Institute, Imperial College London"],"disclosure":"Speaker’s Bureau: AstraZeneca [Corticosteroid insensitivity in severe asthma]. Consultant/Advisory Boards: Vectura [Anti-IL-5]; AstraZeneca [Anti-IL-5R (Benralizumab)]."},{"name":"Nezam H Afdhal, MD, FRCPI","credentials":["Senior Physician in Hepatology\n","Beth Israel Deaconess Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie; BMS; Gilead [HCV Studies]. Consultant/Advisory Boards: AbbVie; Echosens; Gilead Sciences; GlaxoSmithKline; Jannsen Pharmaceutica; Ligand; Merck & Co; Novartis International AG; Spring Bank Pharmaceuticals; TRIO HealthCare [Liver Disease]. Equity Ownership/Stock Options: Spring Bank Pharmaceuticals [HBV, RSV]. Employment: Spring Bank Pharmaceuticals [HBV, RSV] - No relevant conflict on topic."},{"name":"Asghar Aghamohammadi, MD, PhD","credentials":["Professor of Pediatrics\n","Tehran University of Medical Sciences"],"disclosure":""},{"name":"Sam Ahn, MD","credentials":["Assistant Clinical Professor of Medicine/Pediatrics\n","University of Arizona School of Medicine"],"disclosure":""},{"name":"Wei Ai, MD, PhD","credentials":["Clinical Associate Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Mübeccel Akdis, MD, PhD","credentials":["Head of Immunodermatology\n","Swiss Institute of Allergy and Asthma Research (SIAF)"],"disclosure":""},{"name":"Cem Akin, MD, PhD","credentials":["Professor of Medicine \n","University of Michigan"],"disclosure":"Consultant/Advisory Boards: Deciphera [Mastocytosis]; Patara Pharma [Mastocytosis (Cromolyn)]; Novartis [Mastocytosis (Midostaurin)]. Patent Holder: LAD2 cell line [Mast cells]."},{"name":"Praveen Akuthota, MD","credentials":["Associate Clinical Professor\n","University of California, San Diego"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Severe asthma, eosinophil biology]. Consultant/Advisory Boards: GlaxoSmithKline [EGPA (Mepolizumab)]; AstraZenca [Asthma (Benralizumab)]; Ambrx [Breast cancer]."},{"name":"Doerthe A Andreae, MD","credentials":["Assistant Professor\n","Penn State Medical Center"],"disclosure":""},{"name":"Rajesh Aneja, MD, FAAP","credentials":["Associate Professor \n","Department of Critical Care Medicine\n","University of Pittsburgh School of Medicine"],"disclosure":""},{"name":"Gerald B Appel, MD","credentials":["Section Editor — Glomerular Diseases\n","Professor of Medicine\n","Columbia University College of Physicians and Surgeons"],"disclosure":"Grant/Research/Clinical Trial Support: Regulus Therapeutics [Alport syndrome (RG-012, for injection)]; Bristol-Myers Squibb [Focal Segmental Glomerulosclerosis (Abatacept)]; Achillion [C3 Glomerulopathies (ACH-0144471, tablets)]; EMD Serono [Immunoglobulin A nephropathy (Atacicept)]; Reatta [Alport syndrome (Bardoxolone)]; Mallinkrodt [Focal Segmental Glomerulosclerosis (Corticotropin)]; Chemocentryx [C3 Glomerulopathies (Avacopan)]; Chemocentryx [Anti-Neutrophil Cytoplasmic Antibody Vasculitis (Avacopan)]. Speaker's Bureau: Genentech [Vasculitis (Rituximab)]; Sanofi [Side effects (Alemtuzumab)]. Consultant/Advisory Boards: Genentech; Takeda Pharmaceuticals; Bristol-Myers Squibb; Mallinckrodt Pharmaceuticals; EMD Serono; Merck; Pfizer; Genzyme-Sanofi; Omeros; Achillion Pharmaceuticals; Ionis; Reatta; Chemocentryx [Immunosuppressives (Drugs under development for immunosuppression)]."},{"name":"Andrea J Apter, MD, MSc, MA","credentials":["Professor of Medicine\n","Section of Allergy & Immunology, Division of Pulmonary, Allergy, Critical Care Medicine\n","Perelman School of Medicine, University of Pennsylvania"],"disclosure":""},{"name":"Steven M Archer, MD","credentials":["Professor\n","University of Michigan, Department of Ophthalmology and Visual Sciences"],"disclosure":""},{"name":"Riccardo Asero, MD","credentials":["Head Ambulatorio di Allergologia\n","Clinica San Carlo, Paderno Dugnano (MI), Italy"],"disclosure":""},{"name":"Jon C Aster, MD","credentials":["Professor of Pathology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Regeneron [Hematologic malignancies (Notch inhibitors)]; Lilly [Hematologic malignancies (Notch inhibitors)]; Cellestia [Hematologic malignancies (Notch inhibitors)]; Anastasis [Hematologic malignancies (Notch inhibitors)]. Equity Ownership/Stock Options: Cellestia; Anastasis."},{"name":"John P Atkinson, MD","credentials":["Samuel B Grant Professor of Medicine\n","Professor of Molecular Microbiology\n","Chief, Division Rheumatology\n","Washington University School of Medicine"],"disclosure":""},{"name":"Antoine Azar, MD","credentials":["Assistant Professor of Medicine\n","Division of Allergy and Clinical Immunology\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"John W Baddley, MD, MSPH","credentials":["Professor of Medicine\n","Birmingham VA Medical Center\n","University of Alabama at Birmingham"],"disclosure":"Consultant/Advisory Boards: Merck [Fungal/transplant]. Other Financial Interest: Pfizer [Rheumatoid arthritis (tofacitinib)]; R-Pharma [Rheumatoid arthritis (olofizumab)]."},{"name":"Ronald C Balkissoon, MD","credentials":["Associate Professor of Medicine\n","University of Colorado Health Sciences Center"],"disclosure":"Speaker’s Bureau: Astra Zeneca [COPD (Budesonide/formoterol)]; Sunovion [COPD (Arformoterol tartrate, indacaterol/glycopyrolate)]; Genentech [Asthma (Omalizumab)]. Consultant/Advisory Boards: Astra Zeneca [COPD (Budesonide/formoterol)]; Sunovion [COPD (Arformoterol tartrate, indacaterol/glycopyrolate)]; Genentech [Asthma (Omalizumab)]."},{"name":"Zuhair K Ballas, MD","credentials":["Professor of Medicine\n","University of Iowa"],"disclosure":"Consultant/Advisory Boards: Immune Deficiency Foundation [Counseling for immunodeficiency patients and clinicians]; Checkmate Pharma [CpG in tumor immunotherapy (Products in trial)]."},{"name":"Mark Ballow, MD","credentials":["Professor of Pediatrics\n","All Children’s Hospital\n","University of South Florida School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial (Immunoglobulin)]; Shire [Immunoglobulin trial (Immunoglobulin)]. Speaker's Bureau: Shire [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial (Immunoglobulin)]. Consultant/Advisory Boards: Grifols [Immunodeficiency (Immunoglobulin)]; CSL Behring [Immunodeficiency (Immunoglobulin)]; Shire [Immunodeficiency (Immunoglobulin)]. Other Financial Interest (Data Safety Monitoring Boards): Prometic; CSL Behring; Green Cross [Immunoglobulin]."},{"name":"Aleena Banerji, MD","credentials":["Associate Professor\n","Training Program Director\n","Massachusetts General Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Hereditary angioedema (Icatibant)]; CSL [Hereditary angioedema (Cinryze, Berinert)]. Consultant/Advisory Boards: Shire [Hereditary angioedema (Icatibant)]; Alnylam [Hereditary angioedema]; CSL [Hereditary angioedema (Berinert)]; Biocryst [Hereditary angioedema (No product FDA approved yet)]."},{"name":"Kathleen C Barnes, PhD","credentials":["Director, Biomedical Informatics and Personalized Medicine Center and Division\n","University of Colorado School of Medicine"],"disclosure":""},{"name":"Peter J Barnes, DM, DSc, FRCP, FRS","credentials":["Editor-in-Chief — Pulmonary and Critical Care Medicine\n","Section Editor — Asthma\n","Professor of Medicine\n","National Heart and Lung Institute, Imperial College, London"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Asthma, COPD (Symbicort)]; GSK [Asthma, COPD (Advair, fluticasone furoate, vilanterol)]; Novartis [COPD (Indacaterol)]; Boehringer [COPD (Tiotropium, olodaterol)]; Chiesi [Asthma, COPD (Foster)]; Pfizer [COPD]; Takeda [COPD (Roflumilast)];. Speaker's Bureau: AstraZeneca [Asthma (Symbicort)]; Pfizer [COPD (Tiotropium)]; Novartis [COPD (Indacaterol, glucopyrolate, Ultibro)]; Boehringer [COPD (Tiotropium, olodaterol)]; Chiesi [Asthma (Foster)]. Consultant/Advisory Board: AstraZeneca [Asthma]; GSK [Asthma]; Pfizer [COPD]; Novartis [COPD]; Boehringer [COPD]; Chiesi [COPD]; Teva [COPD]; Glenmark [COPD]; Zambon [Asthma]."},{"name":"John G Bartlett, MD","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor — HIV; Pulmonary Infections\n","Professor Emeritus\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Michael Barza, MD","credentials":["Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Maria G Belvisi, PhD","credentials":["Professor of Respiratory Pharmacology\n","National Heart & Lung Institute, Imperial College London"],"disclosure":""},{"name":"Nancy Berliner, MD","credentials":["Professor of Medicine\n","Harvard Medical School\n","H. Franklin Bunn Professor of Hematology and Chief, Division of Hematology \n","Brigham and Women's Hospital"],"disclosure":""},{"name":"Bonnie L Bermas, MD","credentials":["Professor of Medicine\n","UT Southwestern Medical Center"],"disclosure":""},{"name":"David I Bernstein, MD","credentials":["Professor of Clinical Medicine and Environmental Health\n","University of Cincinnati College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Glaxo, TEVA, Astra Zeneca, Pearl, Novartis, Genentech, Circassia, Pfizer, Mylan, Boeringer Ingelheim, Amgen, Array [Clinical trials of asthma therapies, new COPD drugs, new forms of immunotherapy, biologics for treatment of asthma or hives]. Speaker's Bureau: Merck, Astra Zeneca(Asthma management). Consultant/Advisory Boards: TEVA, Merck, Glaxo [Anti-IL5 for asthma, sublingual immunotherapy]."},{"name":"Jonathan A Bernstein, MD","credentials":["Professor of Medicine\n","University of Cincinnati College of Medicine"],"disclosure":""},{"name":"Leonard Bielory, MD","credentials":["Professor of Medicine\n","Thomas Jefferson University Kimmel School of Medicine\n","Professor of Medicine\n","Rutgers University"],"disclosure":""},{"name":"Jack JH Bleesing, MD, PhD","credentials":["Professor of Pediatrics\n","Cincinnati Children's Hospital Medical Center"],"disclosure":""},{"name":"Kimberly G Blumenthal, MD, MSc","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"S Allan Bock, MD","credentials":["Research Affiliate, Department of Pediatrics\n","National Jewish Health\n","Clinical Professor, Department of Pediatrics\n","Children's Hospital Colorado"],"disclosure":""},{"name":"Francisco A Bonilla, MD, PhD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Associate Professor of Pediatrics\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Charles River Associates International (Germany) GmbH [Consultant(Genetics of immunodeficiency)]; Grand Rounds Health [Consultant(Patient care)]; Green Cross, Parexel [DSM(Immunoglobulin therapy)]; Guidepoint Global Advisors [Consultant(General immunodeficiency)]; Health Resources Services Administration/HHS [Consultant(Vaccine injury)]; Immune Deficiency Foundation [Consultant(Patient care / Advisory board)]; Louis August Jonas Foundation [Board Member]; Sarepta [Consultant(Biologic therapy)]."},{"name":"Peter A L Bonis, MD","credentials":["Chief Medical Officer of Clinical Effectiveness (UpToDate, Clinical Drug Information, and Emmi Solutions)\n","Deputy Editor — Gastroenterology/Hepatology\n","Adjunct Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Louis-Philippe Boulet, MD","credentials":["Professor of Medicine\n","Laval University"],"disclosure":"Grant/Research/Clinical Trial Support: Non profit grants-Asmacure [Asthma (ASM-024)], AstraZeneca [Asthma (Benralizumab)], GlaxoSmithKline[Asthma (NA)], Novartis[Asthma (Xolair)], Ono Pharma\r\n[Asthma (ONO-6950)], Sanofi [Asthma (Dupilumab)]. Speaker’s Bureau: Lecture fees from AstraZeneca [Asthma (Benralizumab)], Novartis [Asthma (Xolair)], Methapharm [Asthma (N/A)]. Consultant/Advisory Boards: AstraZeneca [Asthma (Benralizumab)], Novartis [Asthma (Xolair)]."},{"name":"Lee H Bouwman, MD, PhD, FEBVS","credentials":["Vascular Surgeon\n","Atrium Medical Center, Heerlen, The Netherlands"],"disclosure":""},{"name":"Melinda J Braskett, MD","credentials":["Assistant Professor, Clinical Pediatrics\n","Division of Clinical Immunology and Allergy\n","Children's Hospital Los Angeles\n","Keck School of Medicine at University of Southern California"],"disclosure":""},{"name":"Nancy L Breisch, PhD","credentials":["Senior Research Associate\n","University of Maryland"],"disclosure":""},{"name":"Heimo Breiteneder, PhD","credentials":["Professor of Medical Biotechnology\n","Medical University of Vienna, Vienna, Austria"],"disclosure":""},{"name":"Jerry D Brewer, MD","credentials":["Assistant Professor of Dermatology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Kees Brinkman, MD, PhD","credentials":["Department of Internal Medicine\n","Onze Lieve Vrouwe Gasthuis, Amsterdam, The Netherlands"],"disclosure":"Consultant/Advisory Boards: BMS [cART (didanosine, stavudine, atazanavir)]; Viiv [cART (zidovudine, abacavir, lamivudine, dolutegravir)]; Gilead [cART (tenofovir, emtricitabine, elvitegravir)]; Jansen [cART (rilpiverin, darunavir)]; MSD [cART (raltegravir)]."},{"name":"Maarten W Bronkhorst, MD, PhD, FEBS, FRCS","credentials":["Attending Trauma Surgeon\n","Haaglanden Medical Center"],"disclosure":""},{"name":"Kathleen M Buchheit, MD","credentials":["Instructor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Wesley Burks, MD","credentials":["Executive Dean\n","University of North Carolina School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: FARE; NIH; Wallace Research Foundation [Allergy and immunology]. Consultant/Advisory Boards: ActoGeniX; Adept Field Solutions; Aimmune Therapeutics; Dynavax Technologies Corp; FARE; Genentech; GLG Research; Insys Therapeutics; LEK Consulting; Murdoch Children’s Research Institute; PPD Development; Regeneron Pharmaceuticals; Sanofi US Services; SRA International; UKKO; Valeant Pharmaceuticals North America [Allergy and immunology (Oral Immunotherapy for food, Anti-IgE, Sublingual immunotherapy)]. Equity Ownership/Stock Options: Allertein."},{"name":"Robert Bush, MD","credentials":["Professor Emeritus of Medicine\n","University of Wisconsin, Madison"],"disclosure":"Other Financial Interest: Associate Editor for the Journal of Allergy and Clinical Immunology; Section Editor for Current Allergy and Asthma Reports; Section Editor for Current Opinions in Allergy and Immunology."},{"name":"Angela M Caliendo, MD, PhD","credentials":["Executive Vice Chair of Medicine\n","Brown University"],"disclosure":"Grant/Research/Clinical Trial Support: Hologic [HIV viral load; HSV; respiratory viruses]; T2 Biosystems [Aspergillus diagnosis]. Consultant/Advisory Boards: Roche Molecular [CMV]; Quidel [Molecular diagnostics for infectious diseases]; Cepheid [CMV]; IDbyDNA [Genomic testing for infectious diseases]; DNAe [Molecular diagnostics for infectious diseases]."},{"name":"Matthew E Call, PhD","credentials":["Head of Laboratory, Structural Biology Division\n","The Walter and Eliza Hall Institute of Medical Research\n","Department of Medical Biology\n","The University of Melbourne"],"disclosure":""},{"name":"Ronna L Campbell, MD, PhD","credentials":["Associate Professor of Emergency Medicine\n","Mayo Clinic"],"disclosure":"Consultant/Advisory Boards: INSYS Therapeutics [Anaphylaxis]."},{"name":"Fabio Candotti, MD","credentials":["Associate Professor\n","University Hospital of Lausanne (CHUV)"],"disclosure":""},{"name":"Tara F Carr, MD, FAAAAI","credentials":["Assistant Professor, Medicine and Otolaryngology\n","Department of Medicine, University of Arizona"],"disclosure":"Speaker's Bureau: AstraZeneca [Asthma (Benralizumab)]. Consultant/Advisory Boards: AstraZeneca [Asthma (Benralizumab, budesonide-formoterol)]; Aimmune Therapeutics Inc [Food allergy (AR101)]."},{"name":"André Cartier, MD","credentials":["Clinical Professor of Medicine\n","University of Montreal Medical School, Canada"],"disclosure":""},{"name":"Thomas B Casale, MD","credentials":["Executive Vice President, American Academy of Allergy Asthma and Immunology\n","Professor of Medicine\n","University of South Florida"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; Novartis [Urticaria and asthma (Omalizumab)]. Consultant/Advisory Boards: Genentech; Novartis [Urticaria and asthma (Omalizumab)]."},{"name":"Nathalie Casau-Schulhof, MD","credentials":["Attending Physician in Infectious Diseases\n","St. Francis Medical Center, Long Island, NY"],"disclosure":""},{"name":"Mariana C Castells, MD, PhD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Michelle S Cespedes, MD, MS","credentials":["Associate Professor\n","Division of Infectious Disease\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Consultant/Advisory Boards: Gilead Sciences [HIV]."},{"name":"Nelson J Chao, MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Duke University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Jazz [GVHD (defibrotide)]; NIH [hematopoiesis]."},{"name":"W Winn Chatham, MD","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":""},{"name":"Talal Chatila, MD","credentials":["Denise and David Bunning Professor of Pediatrics\n","Harvard Medical School\n","The Boston Children's Hospital"],"disclosure":""},{"name":"Melvin D Cheitlin, MD","credentials":["Emeritus Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Chia-Yu Chu, MD, PhD","credentials":["Associate Professor - Department of Dermatology\n","National Taiwan University Hospital"],"disclosure":""},{"name":"Marco Cicardi, MD","credentials":["Professor of Medicine\n","Università degli Studi di Milano, Italy"],"disclosure":"Grant/Research/Clinical Trial Support: Shire; CSL Behring; Pharming; BioCryst [Hereditary angioedema (Icatibant, plasma-derived C1INH, recombinant human C1INH, lanadelumab)]. Speaker's Bureau: Shire; CSL Behring; Pharming [Hereditary angioedema (Icatibant, plasma-derived C1INH, recombinant human C1INH)]. Consultant/Advisory Boards: Shire; CSL Behring; BioCryst; Pharvaris; KalVista [Hereditary angioedema (Lanadelumab, subcutaneous C1INH, avoralstat, oral anti-bradykinin, oral anti-kallikrein)]."},{"name":"Thomas D Coates, MD","credentials":["Professor of Pediatrics and Pathology\n","University of Southern California School of Medicine"],"disclosure":"Consultant/Advisory Boards: Apopharma [Iron overload]; Celgene [Thalassemia]."},{"name":"Sachiko T Cochran, MD","credentials":["Professor Emeritus\n","UCLA School of Medicine"],"disclosure":""},{"name":"Myron S Cohen, MD","credentials":["Professor of Medicine, Microbiology, Immunology and Public Health\n","University of North Carolina at Chapel Hill"],"disclosure":"Consultant/Advisory Boards: Merck [Implantable prep agents]; Gilead [HIV therapeutics for prevention and treatment]."},{"name":"John R Cohn, MD","credentials":["Professor of Medicine and Pediatrics\n","Thomas Jefferson University"],"disclosure":""},{"name":"Scott P Commins, MD, PhD","credentials":["Associate Professor of Medicine\n","University of North Carolina School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH (NIAID) [Food allergy]. Speaker's Bureau: Genentech [Asthma, urticarial (Omalizumab)]. Consultant/Advisory Boards: Aimmune [CODIT (Oral immunotherapy)]."},{"name":"Timothy P Cooley, MD","credentials":["Associate Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Morton J Cowan, MD","credentials":["Professor Emeritus of Pediatrics\n","University of California, San Francisco"],"disclosure":"Consultant/Advisory Boards: Bluebird Bio [Thalassemia, sickle cell anemia, adrenoleukodystrophy (Gene therapy)]; Exogen Bio [Radiation therapy (Test for determining susceptibility to radiation therapy)]; Homology Medicines [Sickle cell disease (Gene therapy)]."},{"name":"Gary M Cox, MD","credentials":["Professor of Medicine\n","Duke University Medical Center"],"disclosure":""},{"name":"Peter S Creticos, MD","credentials":["Section Editor — Immunotherapy\n","Associate Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Stallergenes-Greer [Immunotherapy (SLIT)]; Circassia [Immunotherapy (Peptides)]. Consultant/Advisory Boards: Circassia; Greer; ITI [Immunotherapy (SCIT; SLIT)]; Allakos [Cytokine antagonists]; ASIT [AIT]."},{"name":"Charlotte Cunningham-Rundles, MD, PhD","credentials":["David S Gottesman Professor of Immunology\n","Mount Sinai School of Medicine"],"disclosure":""},{"name":"Judith S Currier, MD","credentials":["Professor of Medicine\n","University of California, Los Angeles"],"disclosure":"Grant/Research/Clinical Trial Support: Theratechnologies [HIV Lipodystrophy (Egrifta)]."},{"name":"Donald Cutlip, MD","credentials":["Section Editor — Interventional Cardiology\n","Professor of Medicine\n","Harvard Medical School\n","Beth Israel Deaconess Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Boston Scientific [Transcatheter aortic valve; coronary artery stent]; CeloNova [coronary artery stent]."},{"name":"Susan Cu-Uvin, MD","credentials":["Professor of Obstetrics, Gynecology, and Medicine\n","Brown University"],"disclosure":""},{"name":"Johanna Daily, MD, MSc","credentials":["Section Editor — Malaria\n","Associate Professor, Department of Medicine, Division of Infectious Diseases\n","Albert Einstein College of Medicine"],"disclosure":""},{"name":"Reza Dana, MD, MPH, MSc","credentials":["Claes Dohlman Professor of Ophthalmology\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Ocular surface inflammation]; Dompe [Neurotrophic keratopathy]. Consultant/Advisory Boards: Shire [Dry eyes]. Equity Ownership/Stock: Vision Medicines."},{"name":"Demetre C Daskalakis, MD, MPH","credentials":["Associate Professor\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"Mark DP Davis, MD","credentials":["Professor of Dermatology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Fatma Dedeoglu, MD","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"John F Deeken, MD","credentials":["Associate Professor\n","Virginia Commonwealth University\n","Associate Director for Medical Oncology and Clinical Research\n","Inova Comprehensive Cancer and Research Institute"],"disclosure":""},{"name":"Jeffrey G Demain, MD, FAAAAI","credentials":["Clinical Professor of Pediatrics\n","University of Washington"],"disclosure":""},{"name":"Richard D deShazo, MD","credentials":["Billy S Guyton Distinguished Professor\n","Professor of Medicine and Pediatrics\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"Rajiv Dhand, MD, FCCP, FACP, FAARC","credentials":["Professor and Chairman, Department of Medicine\n","University of Tennessee Graduate School of Medicine"],"disclosure":"Speaker's Bureau: CIPLA [Inhaled antibiotics]. Consultant/Advisory Boards: Mylan [COPD (formoterol fumarate)];  Astra-Zeneca [COPD (Glycopyrrolate and formoterol fumarate)]; Bayer [Ventilator-associated pneumonia (Inhaled amikacin)]; Sunovion [COPD (Inhaled glycopyrrolate)]; GlaxoSmithKline (Inhaled formoterol and glycopyrronium, inhaled amikacin, inhaled glycopyrrolate, inhaled antibiotics, inhaled fluticasone-furoate and vilanterol)."},{"name":"John P Dice, MD","credentials":["Allergy and Immunology\n","Private Practice"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech; Sanofi; TEVA Pharmaceuticals; AstraZeneca; GlaxoSmithKline; Perrigo; DBV Technologies. Speaker's Bureau: TEVA Pharmaceuticals [Asthma, allergy (Beclomethasone dipropionate, albuterol sulfate)]."},{"name":"Mitchell P Dombrowski, MD","credentials":["Professor and Chief, Department of Ob/Gyn\n","Saint John Hospital\n","Wayne State University School of Medicine"],"disclosure":""},{"name":"Jayme Dowdall, MD","credentials":["Instructor, Department of Otology and Laryngology\n","Harvard Medical School"],"disclosure":""},{"name":"Scott Dryden-Peterson, MD","credentials":["Assistant Professor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Lawrence DuBuske, MD","credentials":["Clinical Professor of Medicine\n","George Washington University School of Medicine, Washington, DC"],"disclosure":""},{"name":"Raed A Dweik, MD, FACP, FCCP, FRCP(C), FCCM, FAHA","credentials":["Professor of Medicine\n","Cleveland Clinic Lerner College of Medicine"],"disclosure":""},{"name":"Philippe A Eigenmann, MD","credentials":["Geneva University Hospitals, Pediatric Allergy\n","University of Geneva"],"disclosure":""},{"name":"Keith Elkon, MD","credentials":["Mannik-Henderson Professor of Medicine\n","Head, Division of Rheumatology\n","University of Washington"],"disclosure":""},{"name":"Dirk M Elston, MD","credentials":["Professor and Chair, Department of Dermatology and Dermatologic Surgery\n","Medical University of South Carolina"],"disclosure":""},{"name":"Robert E Esch, PhD","credentials":["Adjunct Professor, School of Natural Sciences\n","Lenoir-Rhyne University"],"disclosure":"Consultant/Advisory Boards: Stallergenes-Greer Allergy [Allergenic extracts]."},{"name":"Amos Etzioni, MD","credentials":["Professor Emeritus of Pediatrics and Immunology\n","The Rappaport Faculty of Medicine, Technion, Haifa"],"disclosure":""},{"name":"Christopher H Fanta, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Anna M Feldweg, MD","credentials":["Director, Editorial Management — UpToDate\n","Deputy Editor — Allergy and Immunology\n","Assistant Professor of Medicine, Part-time\n","Harvard Medical School"],"disclosure":""},{"name":"David J Feller-Kopman, MD","credentials":["Professor of Medicine\n","Johns Hopkins Hospital"],"disclosure":""},{"name":"Fernando C Fervenza, MD, PhD","credentials":["Section Editor — Glomerular Diseases \n","Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial support: Genentech [Membranous nephropathy, Fibrillary GN (Rituximab)]; Mallinckrodt [IgA nephropathy] and FSGS(Corticotropin injection gel)]; Janssen Pharmaceutical [Monoclonal protein-mediated renal diseases (Daratumumab)]. Consultant/Advisory Boards: Alexion pharmaceutical [complement-mediated diseases]; Visterra pharmaceutical [complement-mediated diseases]. Employment: Mayo Clinic."},{"name":"Kevin R Flaherty, MD, MS","credentials":["Section Editor — Interstitial Lung Disease\n","Associate Professor of Medicine\n","University of Michigan Health System"],"disclosure":"Grant/Research/Clinical Trial Support: Boehringer Ingelheim [IPF (Nintedanib)]; Roche/Genentech [IPF (Pirfenidone)]. Consultant/Advisory Boards: Boehringer Ingelheim [IPF (Nintedanib)]; Genetech [IPF (Pirfenidone)]; Roche [IPF (Pirfenidone)]; Veracyte [IPF];  Fibrogen [IPF]; Celgene [ILD]; Sanofi-Genzyme [IPF]."},{"name":"Steven Flamm, MD","credentials":["Chief, Liver Transplantation Program\n","Professor of Medicine\n","Feinberg School of Medicine\n","Northwestern University"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie, Gilead (HCV). Speaker’s Bureau:\t Abbvie, Gilead, Merck (HCV). Consultant/Advisory Boards: Abbvie, Gilead, Merck (HCV)."},{"name":"David M Fleischer, MD","credentials":["Associate Section Head, Pediatric Allergy and Immunology\n","Associate Professor of Pediatrics\n","Children's Hospital Colorado\n","University of Colorado Denver School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Monsanto Company [Food allergy]; Nestle Nutrition Institute [Food allergy]; DBV Technologies [Food allergies (Epicutaneous immunotherapy patch)]; Aimmune Therapeutics [Food allergies (oral immunotherapy)]. Speaker's Bureau: Nestle Nutrition Institute [Food allergy]. Consultant/Advisory Boards: NIAID Coordinating Committee and Expert Panel, Update to the Food Allergy Guidelines, Prevention of Peanut Allergy [Food allergy]; Food Allergy & Anaphylaxis Connection Team (FAACT) [Food allergy]; FARE [Food allergy]; National Peanut Board [Food allergy]; DBV Technologies [Food allergy]; Aimmune Therapeutics [Food allergy]; Intrommune Therapeutics [Food allergy]; Kaleo Pharma [Food allergy]; INSYS Therapeutics [Food allergy]; BEFORE Brands [Food allergy]."},{"name":"Thomas A Fleisher, MD","credentials":["Chief, Department of Laboratory Medicine\n","National Institutes of Health Clinical Center"],"disclosure":""},{"name":"Patricia M Flynn, MD","credentials":["Member, Department of Infectious Diseases\n","St. Jude Children's Research Hospital\n","Professor of Pediatrics\n","University of Tennessee, Memphis"],"disclosure":"Consultant/Advisory Boards: Merck [Febrile neutropenia (Posaconazole)]."},{"name":"Mary Glenn Fowler, MD, MPH","credentials":["Professor, Department of Pathology\n","Johns Hopkins Medical Institutes"],"disclosure":""},{"name":"Michael M Frank, MD","credentials":["Samuel L. Katz Professor of Pediatrics\n","Duke University Medical Center"],"disclosure":"Consultant/Advisory Boards: BioCryst [Data and safety monitoring board hereditary angioedema drugs]; Shire [Data and safety monitoring board hereditary angioedema drugs]."},{"name":"Roy Freeman, MD","credentials":["Professor of Neurology\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Pfizer [Neuropathic pain (Pregabalin)]."},{"name":"Theodore Freeman, MD","credentials":["San Antonio Asthma and Allergy Clinic"],"disclosure":""},{"name":"Timothy J Friel, MD","credentials":["Associate Clinical Professor of Medicine\n","University of South Florida Morsani College of Medicine"],"disclosure":""},{"name":"Daniel E Furst, MD","credentials":["Section Editor — Treatment Issues in Rheumatology\n","Clinical professor, University of Washington, Seattle\n","Clinical professor, University of Florence, Florence, Italy\n","Professor of Rheumatology, University of California in Los Angeles (Emeritus)\n","Director of Research, Pacific Arthritis Associates"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [RA, IBD, PMS, PsA (adalimumab)]; Actelion [SSc (bosentan, macitentan)]; Amgen [RA, IBP, AS, PsA (etanercept)]; BMS [RA, SSc (abatacept)]; Corbus [SSc, SLE (anabasum)]; NIH; Novartis; Pfizer [SSc (sildenafil)]; Roche/Genentech [RA, IBD, AS, SSc (rituximab, tocilizumab)]. Consultant/Advisory Boards: AbbVie [RA, IBD, PMS, PsA (adalimumab)]; Actelion [SSc (bosentan, macitentan)]; Amgen [RA, IBP, AS, PsA (etanercept)]; BMS [RA, SSc (abatacept)]; Cytori [lab test advisory]; Novartis; Pfizer [SSc (sildenafil)]; Roche/Genentech [RA, IBD, AS, SSc (rituximab, tocilizumab)]."},{"name":"Glenn T Furuta, MD","credentials":["Professor of Pediatrics\n","University of Colorado School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Morphotek [Basic research]; Nutricia [clinical research]. Consultant/Advisory Boards: Shire [Consultant]. Patent Holder: Esophageal String test [Eosinophilic esophagitis (Esophageal String Test)]. Equity Ownership/Stock Options: Founder-EnterotTrack [Eosinophilic esophagitis (Esophageal String Test)]."},{"name":"Rajesh T Gandhi, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead [HIV (Tenofovir/emtricitabine/elvitegravir/cobi, Tenofovir/emtricitabine, Tenfovir/emtricitabine/rilpivirine)]; Merck [HIV (Raltegravir)]; Viiv [HIV (Abacavir/lamivudine/dolutegravir, Dolutegravir, Abacavir/lamivudine)]. Consultant/Advisory Boards: Theratechnologies [HIV (Ibalizumab)]."},{"name":"Christopher Gappy, MD","credentials":["Clinical Instructor\n","University of Michigan, Department of Ophthalmology and Visual Sciences"],"disclosure":""},{"name":"Andrew Gennery, MD","credentials":["Clinical Reader/Consultant\n","Newcastle University"],"disclosure":""},{"name":"Lynn B Gerald, PhD, MSPH","credentials":["Endowed Chair and Professor\n","Mel and Enid Zuckerman College of Public Health, University of Arizona"],"disclosure":""},{"name":"Susan L Gillespie, MD, PhD","credentials":["Associate Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":""},{"name":"Marshall J Glesby, MD, PhD","credentials":["Professor of Medicine, Healthcare Policy, and Research\n","Weill Cornell Medical College"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [HIV (research support to my institution)]."},{"name":"Stephen J Gluckman, MD","credentials":["Professor of Medicine\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Jerome Goddard, PhD","credentials":["Extension Professor of Medical and Veterinary Entomology\n","Mississippi State University"],"disclosure":""},{"name":"Adam O Goldstein, MD, MPH","credentials":["Professor\n","Department of Family Medicine\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Beth G Goldstein, MD","credentials":["Adjunct Clinical Assistant Professor\n","Department of Dermatology\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Nirmala Gonsalves, MD","credentials":["Associate Professor of Medicine\n","Northwestern University Feinberg School of Medicine"],"disclosure":"Speakers Bureau: Nutricia [Natural supplements (elemental formula)]."},{"name":"Erika Gonzalez-Reyes, MD","credentials":["Associate Professor of Pediatrics\n","Baylor College of Medicine"],"disclosure":"Speaker’s Bureau: Novartis (Omalizumab therapy). Consultant/Advisory Boards\t: Genentech (Omalizumab therapy)."},{"name":"Carmen Gota, MD","credentials":["Orthopedic and Rheumatologic Institute at Cleveland Clinic\n","Center for Vasculitis Care and Research at Cleveland clinic"],"disclosure":""},{"name":"Jason Gotlib, MD, MS","credentials":["Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Mastocytosis (Midostaurin)]; NIH/NCI [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab vedotin)]; NIH/NCI [Systemic mastocytosis (Ibrutinib)]; Seattle Genetics [Advanced systemic mastocytosis/mast cell leukemia (Brentuximab vedotin)]; Pharmacyclics [Systemic mastocytosis (Ibrutinib)]; Stemline Therapeutics, Inc [High-risk myeloproliferative neoplasms (SL-401)]. Consultant/Advisory Boards: Deciphera Pharmaceuticals [Mastocytosis]; Blueprint Medicines [Mastocytosis]; Plexxikon [Mastocytosis]."},{"name":"Geoffrey S Gottlieb, MD, PhD","credentials":["Professor of Medicine/Infectious Diseases\n","Adjunct Professor of Global Health\n","University of Washington School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [HIV (emtricitabine, tenofovir DF, elvitegravir, cobicistat)]; PrEP (emtricitabine, tenofovir DF)]; Alere [HIV (testing)]; Abbott Molecular Diagnostics [HIV (testing)]; Cerus Corp [HIV (testing)]; Merck [HIV (EFdA, raltegravir)]; Janssen Pharmaceutical [HIV (darunavir)]; Bristol-Meyers Squibb [HIV (BMS-986001)]; ViiV Healthcare [HIV (Cabotegravir)]; Roche Molecular Systems [HIV (testing)]."},{"name":"David F Graft, MD","credentials":["Adjunct Professor of Pediatrics\n","University of Minnesota Medical School"],"disclosure":""},{"name":"Leslie C Grammer, MD","credentials":["Professor of Medicine\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"Albert Greene, PhD","credentials":["Entomologist and National IPM Coordinator\n","US General Services Administration"],"disclosure":""},{"name":"Marion Groetch, MS, RD, CDN","credentials":["Director of Nutrition Services\n","Jaffe Food Allergy Institute\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Consultant/Advisory Boards: Nutricia North America and Mead Johnson [CME lectures with fully control over content (Amino acid-based hypoallergenic formulas)]."},{"name":"Jerome E Groopman, MD","credentials":["Dina and Raphael Recanati Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Eyal Grunebaum, MD","credentials":["Associate Professor in Pediatrics\n","University of Toronto"],"disclosure":""},{"name":"Michael Gurish, PhD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Arete Discoveries [Mast cell biology and multiple sclerosis (Proprietary research)]. Other Financial Interest: Expert witness for Conway, Homer, and Chin-Caplan [Autoimmunity (Provide expert opinions)]."},{"name":"Autumn Chandler Guyer, MD","credentials":["Assistant Clinical Professor of Medicine\n","University of California San Francisco"],"disclosure":""},{"name":"Ian P Hall, MD","credentials":["Professor in Molecular Medicine\n","University Hospital, Nottingham, UK"],"disclosure":""},{"name":"Robert Hallowell, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Daniel L Hamilos, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School\n","Physician\n","Massachusetts General Hospital"],"disclosure":"Consultant/Advisory Boards: Sanofi [Drug development (Dupilumab for nasal polyposis)]; Regeneron [Drug development (Dupilumab for nasal polyposis)]; Genentech [Drug development (Omalizumab for nasal polyposis)]; AstraZeneca [Drug development (Benralizumab for nasal polyposis)]."},{"name":"Robert G Hamilton, PhD, DABMLI, FAAAAI","credentials":["Professor of Medicine and Pathology\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Pedram Hamrah, MD","credentials":["New England Eye Center/Tufts Medical Center\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Allergan [Dry eye]; Tissue Tech [Neurotrophic keratopathy]; GlaxoSmithKline [Dry eye]; Coopervision [Contact lens discomfort]; Dompe [Neuropathic pain]; Shire [Dry eye]; Bausch and Lomb [Inflammation]. Consultant/Advisory Boards: Shire [Dry eyes (Lifitegrast)]; Allergan [Dry eyes]; Jade [Neurotrophic keratopathy]; Valeant [Dry eyes (Hydroxypropyl cellulose ophthalmic insert)]; Dompe [Neurotrophic keratopathy]; Aeri Pharmaceuticals [Glaucoma]; Stemnion [Dry eye]; Santen [Dry eye]; Eyegate [Wound healing]; Revision optics [Corneal inlays]; Heidelberg Engineering [Corneal imaging]."},{"name":"Susan M Harding, MD, FCCP, AGAF","credentials":["Section Editor — Diagnostic Testing\n","Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":""},{"name":"Kohei Hasegawa, MD, MPH","credentials":["Assistant Professor \n","Harvard Medical School"],"disclosure":""},{"name":"David Heiden, MD","credentials":["Department of Ophthalmology\n","California Pacific Medical Center\n","San Francisco, CA\n","\n","Medical Director, AIDS Eye Initiative\n","Seva Foundation\n","Berkeley, CA"],"disclosure":""},{"name":"Lucie Heinzerling, MD, PhD, MPH","credentials":["Professor\n","University Hospital Erlangen, Erlangen, Germany"],"disclosure":""},{"name":"Leslie Hendeles, PharmD","credentials":["Professor Emeritus\n","University of Florida"],"disclosure":""},{"name":"Vivian P Hernandez-Trujillo, MD","credentials":["Clinical Associate Professor of Pediatrics\n","Herbert Wertheim School of Medicine\n","Florida International University"],"disclosure":"Speaker's Bureau: MEDA; Bayer [Asthma and allergy (Azelastine/fluticasone intranasal, Loratadine, Flunisolide ICS)]; CSL (20% Immune Globulin). Consultant/Advisory Boards: Bayer [Asthma and allergy (Azelastine/fluticasone intranasal, loratadine, flunisolide ICS)]; Kaleo (Epinephrine Autoinjector); Shire/Baxalta [Primary Immunodeficiency (Immune Globulin); Novartis [Urticaria]; Thermo Fisher [Food allergy]."},{"name":"Dean Hess, RRT, PhD","credentials":["Teaching Associate\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Philips Respironics [Aerosol therapy, mechanical ventilation (Nebulizers, ventilators, monitoring equipment)]; Ventec Life Support [ventilators]; American Board of Internal Medicine [physician credentialing]. Other Financial Interest: Jones and Bartlett [Aerosol therapy, mechanical ventilation (textbooks)]; McGraw Hill royalty [Aerosol therapy, mechanical ventilation (textbooks)]. Employment: Daedalus Enterprises [Aerosol therapy, mechanical ventilation (Respiratory Care journal)]."},{"name":"Patricia L Hibberd, MD, PhD","credentials":["Chair, Department of Global Health\n","Boston University School of Public Health"],"disclosure":""},{"name":"Whitney A High, MD","credentials":["Associate Professor of Dermatology and Dermatopathology\n","University of Colorado School of Medicine"],"disclosure":""},{"name":"Harry R Hill, MD","credentials":["Professor of Pediatrics, Pathology, and Internal Medicine\n","University of Utah School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Horizon Pharmaceutical [Interferon gamma]. Speaker's Bureau: Horizon Pharmaceutical [Interferon gamma]. Consultant/Advisory Board: Horizon Pharmaceutical [Interferon gamma]."},{"name":"Mary Beth Hogan, MD","credentials":["Vice Chair of Pediatric Research\n","Professor of Pediatrics\n","University of Nevada, Las Vegas School of Medicine"],"disclosure":""},{"name":"Steven M Holland, MD","credentials":["Laboratory of Clinical Immunology and Microbiology\n","National Institutes of Health, Bethesda, MD"],"disclosure":""},{"name":"Sandra J Hong, MD","credentials":["Clinical Assistant Professor of Internal Medicine\n","Northeast Ohio Medical University\n","Staff\n","Cleveland Clinic Foundation"],"disclosure":""},{"name":"C Robert Horsburgh, Jr, MD, MUS","credentials":["Professor of Epidemiology, Biostatistics and Medicine\n","Boston University School of Public Health"],"disclosure":""},{"name":"Terzah M Horton, MD, PhD","credentials":["Assistant Professor, Hematology/Oncology\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Takeda Pharmaceuticals/Millennium [Proteasome inhibitors (Bortezomib); Seattle Genetics [Anti-CD30 antibodies (Brentuximab)]."},{"name":"Robert W Hostoffer, DO, FACOP, FAAP, FACOI, FCCP","credentials":["Associate Professor\n","Case Western Reserve University\n","Professor\n","Ohio University"],"disclosure":""},{"name":"William Howe, MD","credentials":["Assistant Clinical Professor\n","University of Colorado Denver School of Medicine"],"disclosure":""},{"name":"Brenna Hughes, MD, MSc","credentials":["Associate Professor of Obstetrics and Gynecology\n","Duke University"],"disclosure":""},{"name":"Gene G Hunder, MD","credentials":["Section Editor — Vasculitis\n","Emeritus Consultant\n","Professor Emeritus\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Peter H Hwang, MD","credentials":["Professor\n","Chief, Division of Rhinology\n","Department of Otolaryngology - Head & Neck Surgery\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Olympus [Sinus surgery (Surgical equipment)]; Medtronic [Sinus surgery (Surgical equipment)]; 480 Biomedical [Drug delivery, sinusitis]; Arrinex [Rhinitis (Medical devices)]. Equity Ownership/Stock Options: Intersect ENT [Drug delivery/sinusitis (Propel)]."},{"name":"Emily P Hyle, MD","credentials":["Instructor\n","Harvard Medical School"],"disclosure":""},{"name":"Michael Ieong, MD","credentials":["Assistant Professor of Medicine\n","Boston University School of Medicine"],"disclosure":""},{"name":"Charles G Irvin, PhD, FERS","credentials":["Professor\n","University of Vermont Department of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: American Lung Association-Airways Clinical Research Centers [Asthma, COPD]. Consultant/Advisory Boards: Methapharm [Bronchial challenge (Methacholine)]; Medical Graphic Corporation [Lung function (CPX equipment)]."},{"name":"Richard S Irwin, MD","credentials":["Professor of Medicine\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"Elliot Israel, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: AstraZeneca [Aspirin-sensitive asthma (Zafirlukast), biologic treatment for aspirin sensitivity (Benralizumab)]; Regeneron/Sanofi [Biologic treatment for aspirin sensitivity (Dupilumab)]; TEVA [Biologic potentially useful for AERD (Reslizumab)] Merch [AERD (Montelukast)]."},{"name":"Deborah S Jacobs, MD","credentials":["Associate Professor of Ophthalmology, Part-Time\n","Harvard Medical School"],"disclosure":""},{"name":"Mark A Jacobson, MD","credentials":["Clinical Health Sciences Professor of Medicine\n","University of California San Francisco"],"disclosure":""},{"name":"Kirsi M Jarvinen-Seppo, MD, PhD","credentials":["Associate Professor of Pediatrics and Medicine\n","University of Rochester School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH NIAID [Breast milk and infant immunology]; Bill and Melinda Gates Foundation [Breast milk antibodies]. Consultant/Advisory Boards: Merck [Allergic rhinitis]; DBV Technologies [Food allergy (Milk epicutaneous patch)]."},{"name":"Grace John-Stewart, MD","credentials":["Professor, Departments of Medicine, Global Health, and Epidemiology\n","University of Washington"],"disclosure":""},{"name":"Christine Johnston, MD, MPH","credentials":["Assistant Professor of Medicine\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Sanofi [HSV vaccine (Phase I study)]; Vical [HSV vaccine (Phase II study)]; Genocea [HSV vaccine (Phase II study)]. Consultant/Advisory Boards: Novavax."},{"name":"Richard B Johnston, Jr, MD","credentials":["Emeritus Professor of Pediatrics\n","University of Colorado School of Medicine\n","National Jewish Health"],"disclosure":""},{"name":"Stephen Jolles, BSc Hons, MBChB Hons, MSc, PhD, FRCP, FRCPath","credentials":["Consultant Clinical Immunologist & Honorary Senior Lecturer\n","Immunodeficiency Centre for Wales\n","University Hospital of Wales"],"disclosure":"Grant/Research/Clinical Trial Support: Baxalta [Immune globulin (Immune globulin subcutaneous, human normal immune globulin)]; UCB Pharma [Autoimmunity (Trial drug Data and Safety Monitoring Board)]; Grifols [Immune globulin (Immune globulin intravenous)]; Biotest [Immune globulin (Intravenous immune globulin)]; Octapharma [Immunoglobulin (Immune globulin intravenous, human normal immunoglobulin, complement C1 esterase inhibitor)]; CSL Behring [Immunoglobulin (Immune globulin subcutaneous, immune globulin intravenous)]; GlaxoSmithKline [Hypereosinophilic syndrome (Mepolizumab)]. Speaker's Bureau: Baxalta [Immune globulin (Immune globulin subcutaneous, human normal immune globulin)]; Biotest [Immune globulin (Intravenous immune globulin)]; Shire [Hereditary angioedema (Icatibant)]; CSL Behring [Immunoglobulin (Immune globulin subcutaneous, immune globulin intravenous)]; LFB [Immune globulin (10% intravenous immune globulin)]. Consultant/Advisory Boards: Baxalta [Immune globulin (Immune globulin subcutaneous, human normal immune globulin)]; UCB Pharma [Autoimmunity (Trial drug Data and Safety Monitoring Board)]; Sobi [Autoinflammation (Anakinra)]; Grifols [Immune globulin (Immune globulin intravenous)]; Biotest [Immune globulin (Intravenous immune globulin)]; Shire [Hereditary angioedema (Icatibant)]; CSL Behring [Immunoglobulin (Immune globulin subcutaneous, immune globulin intravenous )]; LFB [Immune globulin (10% intravenous immune globulin)]."},{"name":"Jose Joseph-Vempilly, MD","credentials":["Professor of Medicine\n","UCSF, Fresno"],"disclosure":""},{"name":"Sujani Kakumanu, MD","credentials":["Clinical Assistant Professor, Division of Allergy, Pulmonary, and Critical Care Medicine\n","University of Wisconsin Medical School and Public Health \n","Middleton Memorial Veterans Hospital"],"disclosure":""},{"name":"Lawrence D Kaplan, MD","credentials":["Clinical Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Stephen Kells, PhD","credentials":["Associate Professor of Entomology\n","University of Minnesota"],"disclosure":""},{"name":"John M Kelso, MD","credentials":["Section Editor – Anaphylaxis\n","Division of Allergy, Asthma, and Immunology\n","Scripps Clinic, San Diego, CA"],"disclosure":""},{"name":"Stephen F Kemp, MD","credentials":["Professor of Medicine and Pediatrics\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"David A Khan, MD","credentials":["Professor of Medicine and Pediatrics\n","UT Southwestern Medical Center"],"disclosure":"Speaker's Bureau: Genentech [Urticaria (Omalizumab)]. Consultant/Advisory Boards: Aimmune [Food allergy]."},{"name":"Arthur Y Kim, MD, FIDSA","credentials":["Associate Professor of Medicine \n","Harvard Medical School"],"disclosure":""},{"name":"Susan Kim, MD, MMSc","credentials":["Associate Professor of Pediatrics\n","University of California, San Francisco"],"disclosure":""},{"name":"Talmadge E King, Jr, MD","credentials":["Editor-in-Chief — Pulmonary and Critical Care Medicine\n","Section Editor — Interstitial Lung Disease\n","Dean, School of Medicine \n","Vice Chancellor, Medical Affairs\n","University of California San Francisco"],"disclosure":""},{"name":"Steven Kleinman, MD","credentials":["Section Editor — Transfusion Medicine\n","Clinical Professor of Pathology\n","University of British Columbia, Vancouver"],"disclosure":"Consultant/Advisory Boards: Cerus Corp [Pathogen reduction of blood components (Intercept Blood system)]. Equity Ownership/Stock Options: Cerus Corp."},{"name":"Amy D Klion, MD","credentials":["Baltimore, MD"],"disclosure":""},{"name":"Paul E Klotman, MD","credentials":["President, CEO, and Executive Dean\n","Baylor College of Medicine"],"disclosure":"Consultant/Advisory Boards: 98point6 [Clinical decision-making support]. Consultant/Advisory Boards (spouse/partner): 98point6 [Clinical decision-making support]. Equity Ownership/Stock Options: 98point6 [Clinical decision-making support]. Equity Ownership/Stock Options (spouse/partner): 98point6 [Clinical decision-making support]."},{"name":"Alan P Knutsen, MD","credentials":["Director, Pediatric Allergy and Immunology\n","Director, Jeffery Modell Center for Primary Immunodeficiencies\n","Professor of Pediatrics\n","St. Louis University Health Sciences Center"],"disclosure":""},{"name":"Igor J Koralnik, MD","credentials":["Jean Schweppe Armour Professor of Neurology and Medicine\n","Rush Medical College\n","Chair, Department of Neurological Sciences\n","Section Chief, Neuroinfectious Disease\n","Rush University Medical Center"],"disclosure":"Grant/Research Support: Biogen Idec [JC Virus)]. Consultant/Advisory Boards: Medimmune, Johnson & Johnson [JC virus]."},{"name":"Krzysztof Kowal, MD","credentials":["Department of Allergy and Internal Diseases\n","University Medical School, Bialystok, Poland"],"disclosure":"Speaker's Bureau: Stallergenes; Allergopharma; HAL Allergy Group [Allergen immunotherapy (Allergen extracts)]; Chiesi [Asthma (Beclomethasone, formoterol)]; Meda Pharmaceuticals [Asthma (Budesonide, formoterol)]; Berlin Chemie [Allergic rhinitis (Bilastine)]. Consultant/Advisory Boards: GlaxoSmithKline [Asthma (Mepolizumab)]."},{"name":"Michael J Kozal, MD","credentials":["Professor of Medicine\n","Yale University School of Medicine"],"disclosure":"Grant/Research Support: Abbvie, Pfizer, Gilead, Hologic, Glaxo/ViiV, CytoDyn, TiaMed, Bristol-Myers Squibb [HIV, Hepatitis C (ART therapy; HIV/HCV/HSV diagnostics)]."},{"name":"Douglas Krakower, MD","credentials":["Division of Infectious Diseases\n","Beth Israel Deaconess Medical Center\n","\n","Assistant Professor of Medicine, Harvard Medical School\n","\n","Research Scientist, The Fenway Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [HIV prevention (Tenofovir-emtricitabine)]. Other Financial Interest: MED-IQ; Medscape [HIV prevention]."},{"name":"Guha Krishnaswamy, MD, FACP, FCCP, FACAAI, FAAAI, CC-D","credentials":["Professor of Medicine and Pediatrics\n","Wake Forest University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Complications if immune deficiency (Immune globulin)]."},{"name":"Attila Kumánovics, MD","credentials":["Assistant Professor of Pathology\n","University of Utah School of Medicine"],"disclosure":""},{"name":"Irving Kushner, MD","credentials":["Professor Emeritus\n","Case Western Reserve University"],"disclosure":""},{"name":"Robert A Kyle, MD","credentials":["Section Editor — Plasma Cell Disorders\n","Professor of Medicine\n","Mayo Medical School"],"disclosure":"Consultant/Advisory Boards: Celgene Disease Monitoring Committee [Dysproteinemias (lenalidomide, pomalidomide)]; Bristol-Myers Squibb Independent Monitoring Committee [Dysproteinemias (elotuzumab)]; Onyx Pharma (Amgen) Data Monitoring Committee [Dysproteinemias (carfilzomib)]; Pharmacyclics Data Safety Monitoring Board [Dysproteinemias (ibrutinib)]. Other Financial Interest: Pfizer [Lecture on therapy of multiple myeloma, made comments concerning a new Pfizer product and received an honorarium]."},{"name":"Denis Lafreniere, MD","credentials":["Professor and Chief of the Division of Otolaryngology\n","University of Connecticut Health Center"],"disclosure":""},{"name":"Tanya M Laidlaw, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Chiesi USA [Asthma (Zileuton)]; GlaxoSmithKline [Asthma (Mepolizumab)]; Sanofi [Asthma (Dupilumab)]."},{"name":"Alan M Lake, MD","credentials":["Associate Professor of Pediatrics\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Timothy R LaPine, MD","credentials":["Professor of Pediatrics and Pathology\n","University of Utah School of Medicine"],"disclosure":""},{"name":"Dennis K Ledford, MD","credentials":["Professor of Internal Medicine and Pediatrics\n","University of South Florida"],"disclosure":"Grant/Research/Clinical Trial Support: Genentech [Urticaria (Omalizumab)]; AstraZeneca [COPD (Omalizumab)]. Speaker's Bureau: AstraZeneca [Asthma (Budesonide/formoterol)]; Boehringer-Ingelheim [Asthma (Tiotropium)]; Genentech [Asthma/urticaria (Omalizumab)]; Novartis [Asthma/urticaria (Omalizumab)]; MEDA [Rhinitis (Fluticasone/azelastine), asthma (Flunisolide)]; Merck [Rhinitis (Ragweed/grass pollen)]; Circassia [Asthma (Measurement FeNO)]. Consultant/Advisory Boards: Boehringer-Ingelheim [Asthma (Tiotropium)]; AstraZeneca [Asthma]. Other Financial Interest: Expert legal review [Latex allergy, metal allergy, asthma]."},{"name":"Matthew R Leibowitz, MD","credentials":["Chief of the Division of Infectious Diseases\n","Newton-Wellesley Hospital"],"disclosure":""},{"name":"Michael D Leise, MD","credentials":["Assistant Professor of Medicine\n","Mayo Clinic College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Hepatitis C (Grazoprevir, elbasvir)]; Abbvie [Hepatitis C (Glecaprevir/Pibrentasvir)]."},{"name":"Robert F Lemanske, Jr, MD","credentials":["Professor of Pediatrics and Medicine\n","University of Wisconsin School of Medicine and Public Health at Madison, WI"],"disclosure":"Grant/Research/Clinical Trial Support: NHLBI [Asthma (COAST)]; AsthmaNet [Asthma]; ORBEX [Asthma]; CTS [Clinical and translational research]; NIH [Asthma (Inhaled corticosteroids, montelukast, tiotropium, albuterol, azithromycin, prednisone)]; Pharmaxis [Asthma (Mannitol)]; PARK (omalizumab). Speaker's Bureau: Latin American Congress [Asthma]; Allergy and Asthma Foundation of Alaska [Asthma]; Louisiana State University [Asthma]. Other Financial Interest: Elsevier [royalties]."},{"name":"Catherine Lemière, MD","credentials":["Professor of Medicine\n","University of Montreal Medical School"],"disclosure":""},{"name":"Alyssa R Letourneau, MD","credentials":["Instructor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Jerrold H Levy, MD, FAHA, FCCM","credentials":["Professor of Anesthesiology\n","Associate Professor of Surgery\n","Co-Director, Cardiothoracic ICU\n","Duke University Hospital"],"disclosure":""},{"name":"Ofer Levy, MD, PhD","credentials":["Associate Professor\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Crucell (Johnson & Johnson) [Vaccines (Meningococcal and pertussis vaccines)]; Shire [Antimicrobial proteins]. Patent Holder: Use of antimicrobial protein rBPI31 for radiation mitigation."},{"name":"Howard Libman, MD, FACP","credentials":["Professor of Medicine, Emeritus\n","Harvard Medical School"],"disclosure":""},{"name":"Rodger A Liddle, MD","credentials":["Professor of Medicine\n","Duke University Medical School"],"disclosure":""},{"name":"Phillip L Lieberman, MD","credentials":["Clinical Professor of Medicine and Pediatrics\n","University of Tennessee College of Medicine"],"disclosure":"Speaker's Bureau: MYLAN [Rhinitis (Azelastine/fluticasone nasal spray)]; TEVA [Rhinitis (Beclomethasone)]."},{"name":"Peter A Lio, MD","credentials":["Clinical Assistant Professor of Dermatology and Pediatrics\n","Northwestern University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AOBiome [Atopic dermatitis (Topical probiotic spray)]. Speaker's Bureau: Regeneron Pharmaceuticals [Atopic dermatitis (Dupilumab)]; Pfizer [Atopic dermatitis (Crisaborole)]. Consultant/Advisory Boards: Sanofi [Atopic dermatitis (Dupilumab)]; Pfizer [Atopic dermatitis (Crisaborole)]; Realm Therapeutics [Atopic dermatitis (Future medication)]."},{"name":"M Kathryn Liszewski, PhD","credentials":["Assistant Professor of Medicine\n","Washington University School of Medicine"],"disclosure":""},{"name":"Augusto A Litonjua, MD","credentials":["Professor of Medicine and Pediatrics\n","Golisano Children's Hospital of University of Rochester Medical Center"],"disclosure":"Consultant/Advisory Boards: AstraZeneca, Inc [AIRS Forum Committee]."},{"name":"Mark Liu, MD","credentials":["Associate Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: GlaxoSmithKline [Asthma and COPD (Mepolizumab); Medimmune [Asthma and COPD (Tezepelumab)]; Boehringer Ingelheim [Asthma and COPD]; Amgen [Asthma and COPD (Brodalumab)]; Sanofi Aventis [Asthma and COPD (Dupilumab)]."},{"name":"Aidan Long, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Genentech [Asthma]; Novartis [Asthma]; Astra-Zeneca [Asthma]."},{"name":"Fred A Lopez, MD","credentials":["Richard Vial Professor and Vice Chair\n","Louisiana State University School of Medicine"],"disclosure":""},{"name":"Douglas R Lotz, MD","credentials":["Clinical Instructor in Pediatrics (Gratis)\n","University of Louisville School of Medicine"],"disclosure":"Speaker's Bureau: Shire [Hereditary angioedema]."},{"name":"Gregory M Lucas, MD, PhD","credentials":["Professor of Medicine\n","Johns Hopkins University"],"disclosure":""},{"name":"J Mark Madison, MD","credentials":["Professor of Medicine and Microbiology and Physiological Systems\n","University of Massachusetts Medical School"],"disclosure":""},{"name":"John P Manis, MD","credentials":["Assistant Professor of Pathology\n","Harvard Medical School\n","Joint Program in Transfusion Medicine, Dep"],"disclosure":""},{"name":"Norman M Mann, MD","credentials":["Assistant Clinical Professor, Department of Medicine\n","University of Connecticut School of Medicine"],"disclosure":""},{"name":"Richard J Martin, MD","credentials":["Professor of Medicine\n","University of Colorado Denver, School of Medicine"],"disclosure":"Consultant/Advisory Boards: AstraZeneca [Asthma, COPD, biologics (IL4, 5, and 13]."},{"name":"Ursula A Matulonis, MD","credentials":["Associate Professor of Medicine\n","Harvard Medical School \n","Director/Program Leader\n","Medical Gynecologic Oncology\n","Dana-Farber Cancer Institute"],"disclosure":""},{"name":"Marcus Maurer, MD","credentials":["Professor of Dermatology and Allergy\n","Charité – Universitätsmedizin Berlin, Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Urticaria (Omalizumab)]; Genentech [Urticaria (Omalizumab)]; Uriach [Urticaria (Rupatadine)]; Abbott Laboratories [Urticaria (Rupatadine)]; FAES [Urticaria (Bilastine)]; UCB [Urticaria (Levocetirizine)]; Moxie [Urticaria (TempTest)]. Consultant/Advisory Boards: Novartis [Urticaria (Omalizumab)]; Genentech [Urticaria (Omalizumab)]; Uriach [Urticaria (Rupatadine)]; Abbott Laboratories [Urticaria (Rupatadine)]; FAES [Urticaria (Bilastine)]; MSD [Urticaria (Desloratadine)]; Almirall [Urticaria (Ebastine)]; UCB [Urticaria (Levocetirizine)]; Moxie [Urticaria (TempTest)]; Sanofi [Urticaria (Fexofenadine)]."},{"name":"Toby Maurer, MD","credentials":["Professor of Dermatology\n","University of California, San Francisco, School of Medicine"],"disclosure":""},{"name":"Kenneth H Mayer, MD","credentials":["Infectious Disease Attending and Director of HIV Prevention Research\n","Beth Israel Deaconess Medical Center\n","Professor of Medicine\n","Harvard Medical School\n","Medical Research Director\n","The Fenway Institute"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [PrEP (Tenofovir-emtricitabine)]; ViiV Healthcare [PrEP (Cabotegravir)]."},{"name":"Jennifer W McCallister, MD, FACP, FCCP","credentials":["Associate Professor of Clinical Internal Medicine\n","The Ohio State University Wexner Medical Center"],"disclosure":""},{"name":"Meredith C McCormack, MD, MHS","credentials":["Assistant Professor of Medicine\n","Medical Director, Pulmonary Function Laboratory Pulmonary and Critical Care Medicine Johns Hopkins University"],"disclosure":""},{"name":"Douglas McDonald, MD, PhD","credentials":["Assistant Professor of Pediatrics\n","Boston Children's Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"Malcolm McDonald, PhD, FRACP, FRCPA","credentials":["Associate Professor\n","School of Medicine and Dentistry, James Cook University"],"disclosure":""},{"name":"Iain B McInnes, FRCP, PhD","credentials":["Professor of Medicine\n","University of Glasgow"],"disclosure":"Grant/Research Support: Pfizer [Inflammatory arthritis (Etanercept, tofacitinib)]; UCB [Inflammatory arthritis (Certolizumab)]; Janssen [Inflammatory arthritis (Ustekinumab)]; BMS [Inflammatory arthritis (Abatacept)]; Celgene. Consultant/Advisory Boards: Pfizer [Inflammatory arthritis (Etanercept, tofacitinib)]; UCB [Inflammatory arthritis (Certolizumab)]; Janssen [Inflammatory arthritis (Ustekinumab)]; Novartis [Inflammatory arthritis (Secukinumab)]; AbbVie [Inflammatory arthritis (Adalimumab)]; BMS [Inflammatory arthritis (Abatacept)]; MSD [Inflammatory arthritis (Golimumab)]; Lilly [Inflammatory arthritis (Baricitinib)]."},{"name":"Dick Menzies, MD, MSc","credentials":["Professor of Medicine and of Epidemiology & Biostatistics\n","Montreal Chest Institute, McGill University"],"disclosure":""},{"name":"Rachel Miller, MD, FAAAAI","credentials":["Professor of Medicine (In Pediatrics) and Environmental Health Sciences\n","NYPH/Columbia University"],"disclosure":""},{"name":"Jeffrey E Ming, MD, PhD","credentials":["Adjunct Assistant Professor of Pediatrics\n","The Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Payam Mohammadinejad, MD","credentials":["Research Fellow\n","Tehran University of Medical Sciences"],"disclosure":""},{"name":"Anthony Montanaro, MD, FAAAAI","credentials":["Professor of Medicine\n","Oregon Health and Science University"],"disclosure":""},{"name":"Rachel A Nardin, MD","credentials":["Assistant Professor of Neurology\n","Harvard Medical School"],"disclosure":""},{"name":"Robert S Negrin, MD","credentials":["Section Editor — Bone Marrow Transplantation\n","Professor of Medicine\n","Stanford University School of Medicine"],"disclosure":"Consultant/Advisory Boards: Amgen [Immuno-oncology]; Jazz Pharmaceuticals [Veno-occlusive disease (Defibrotide)]; Cell Source [Cellular therapy]; Magenta Pharmaceuticals [Transplantation]. Equity Ownership/Stock Options: Concentrx [Cellular immunotherapy]; Magenta Pharmaceuticals [Transplantation]; Cell Source [Cellular therapy]. Other Financial Interest: American Society of Hematology [Editor in Chief of \"Blood Advances\"]."},{"name":"Harold Nelson, MD","credentials":["Professor of Medicine\n","National Jewish Health\n","University of Colorado Denver School of Medicine"],"disclosure":""},{"name":"Patrick Niaudet, MD","credentials":["Section Editor — Pediatric Nephrology\n","Professor of Pediatrics\n","Hôpital Necker-Enfants Malades, Paris, France"],"disclosure":""},{"name":"Tim Niehues, MD","credentials":["Professor of Pediatrics\n","HELIOS Klinikum Krefeld\n","Academic Hospital, RWTH Aachen University"],"disclosure":""},{"name":"Karin Nielsen-Saines, MD, MPH","credentials":["Professor of Clinical Pediatrics\n","Division of Infectious Diseases\n","UCLA Mattel Children's Hospital \n","David Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Sally A Noone, RN, MSN","credentials":["Clinical Research Manager\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Consultant/Advisory Boards: Aimmune Therapeutics [Peanut allergy (Quality of Life tool)]."},{"name":"Luigi D Notarangelo, MD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Bethesda, MD"],"disclosure":""},{"name":"Anna Nowak-Węgrzyn, MD","credentials":["Associate Professor of Pediatrics\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: DBV Technologies; ITN/NIAID; Astellas Pharmaceutical [Future therapies for food allergy]. Speaker's Bureau: Thermo Fisher Scientific [Oral allergy syndrome]; International FPIES Association [FPIES, unpaid advisor]. Consultant/Advisory Boards: Gerber Nutrition Institute; Merck; ALK-Abello [Sublingual immunotherapy trials for pollen allergy]."},{"name":"Paul M O'Byrne, MB, FRSC","credentials":["EJ Moran Campbell Professor\n","McMaster University, Canada"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Asthma (Budesonide/Formoterol)]; GlaxoSmithKline [Asthma (Salmeterol/Fluticasone)]; Genentech [Asthma (Omalizumab)]; Novartis [Asthma]. Consultant/Advisory Boards: AstraZeneca [Asthma (Budesonide/Formoterol)]; Boehringer [Asthma (Salmeterol/Fluticasone)]; GlaxoSmithKline [Asthma (Omalizumab)]; Merck [Asthma (Tiotropium)]; Novartis [Asthma]."},{"name":"Hans D Ochs, MD","credentials":["Professor of Pediatrics\n","University of Washington"],"disclosure":""},{"name":"Puneet Opal, MD, PhD","credentials":["Associate Professor of Neurology\n","Feinberg School of Medicine, Northwestern University"],"disclosure":"Grant/Research/Clinical Trial Support: Biohaven [Spinocerebellar ataxia (Trigriluzole)]."},{"name":"Jordan S Orange, MD, PhD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Professor of Pediatrics\n","Chief of Immunology, Allergy, and Rheumatology\n","Baylor College of Medicine\n","Texas Children's Hospital"],"disclosure":"Consultant/Advisory Boards: ADMA Biologics; Shire; CSL Behring; Grifols [Primary immunodeficiency (IVIG, SCIG)]."},{"name":"Liron Pantanowitz, MD","credentials":["Professor of Pathology\n","University of Pittsburgh Medical Center"],"disclosure":""},{"name":"Nereida A Parada, MD","credentials":["Associate Professor of Medicine\n","Section of Pulmonary, Critical Care and Environmental Medicine\n","Tul"],"disclosure":""},{"name":"Kenneth Paris, MD, MPH","credentials":["Associate Professor of Pediatrics\n","LSU Health Sciences Center New Orleans"],"disclosure":"Speaker's Bureau: Shire [Immunodeficiency diagnosis and treatment (Immunoglobulin)]. Consultant/Advisory Boards: Shire [Immunodeficiency diagnosis and treatment (Immunoglobulin)]; CSL Behring [Immunodeficiency diagnosis and treatment (Immunoglobulin)]."},{"name":"Rodolfo Pascual, MD","credentials":["Associate Professor of Internal Medicine\n","Wake Forest University Health Sciences"],"disclosure":""},{"name":"Mark S Pasternack, MD","credentials":["Associate Professor of Pediatrics\n","Harvard Medical School"],"disclosure":"Equity Ownership: Merck."},{"name":"Zara M Patel, MD","credentials":["Assistant Professor\n","Division of Rhinology\n","Department of Otolaryngology - Head and Neck Surgery\n","Stanford University School of Medicine"],"disclosure":""},{"name":"Sarita U Patil, MD","credentials":["Instructor, Allergy and Immunology\n","Massachusetts General Hospital\n","Harvard Medical School"],"disclosure":""},{"name":"David Peden, MD","credentials":["Harry S. Andrews Distinguished Professor of Pediatrics\n","The University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Stanford L Peng, MD, PhD","credentials":["Clinical Assistant Professor\n","University of Washington"],"disclosure":""},{"name":"Elena E Perez, MD, PhD","credentials":["Associate\n","Allergy Associates of the Palm Beaches"],"disclosure":"Speaker's Bureau: CSL Behring [Immunology (Intravenous immune globulin)]. Consultant/Advisory Boards: CSL Behring [Immunology (Intravenous immune globulin)]; Shire [Immunology (Intravenous immune globulin)]; Grifols [Immunology (Intravenous immune globulin)]."},{"name":"John R Perfect, MD","credentials":["Professor of Medicine\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [Antifungal agents (Posaconazole, isavconazole, AmBisome)]; Astellas [Antifungal agents (Posaconazole, isavuconazole, AmBisome)]; Pfizer [Antifungal agents (Voriconazole, fluconazole)]. Consultant/Advisory Boards: Merck [Antifungal agents (Posaconazole, isavuconazole, AmBisome)]; Astellas [Antifungal agents (Posaconazole, isavuconazole, AmBisome)]."},{"name":"Holly Perry, MD","credentials":["Assistant Professor of Pediatrics\n","Tufts University School of Medicine"],"disclosure":""},{"name":"Stephen Peters, MD, PhD, FACP, FCCP, FAAAAI, FCPP","credentials":["Professor of Medicine and Pediatrics\n","Wake Forest University Health Sciences"],"disclosure":"Grant/Research/Clinical Trial Support: NHLBI [AsthmaNet, SARP, SPIROMICS]; American Lung Association [Asthma clinical research centers]; NIAID [Asthma and Allergic Disease Data Safety Monitoring Board]; \r\nConsultant/Advisory Boards: Astra-Zeneca [Asthma and COPD]; Genentech [Asthma and  COPD, DSMB]; Medimmune [Asthma and COPD]; Novartis [Asthma and COPD]; Regeneron Sanofi-Aventis [Asthma]; Novartis [Asthma, DSMB]; Pfizer [Asthma]; Quintiles [Asthma]; TEVA [Asthma]."},{"name":"Marc Peters-Golden, MD","credentials":["Professor of Internal Medicine\n","University of Michigan Health System"],"disclosure":""},{"name":"Werner J Pichler, MD","credentials":["Professor of Clinical Immunology (Emeritus)\n","University of Bern, Switzerland"],"disclosure":"Grant/Research/Clinical Trial Support: Menarini Group [Possible immune reactions to febuxostat]; Teleflex [Possible allergic reactions to disinfectants]; GlaxoSmithKline (ViiV) [Possible allergic reactions to a beta-lactam-containing metabolite]. Consultant/Advisory Boards: Teleflex [Possible allergic reactions to disinfectants]; Roche [Human T cell biology]; Novartis [Immune-related side effects to checkpoint inhibitors; mechanistic considerations]; Biomarin [Allergic reactions to ERT]. Equity Ownership/Stock Options: ADR-AC GmbH (company devoted to diagnosis and research in the field of drug hypersensitivity) - No relevant conflict on topic."},{"name":"Andrew A Pieper, MD, PhD","credentials":["Investigator, The Harrington Discovery Institute \n","\n","Professor of Psychiatry \n","Case Western Reserve University"],"disclosure":""},{"name":"Thomas A E Platts-Mills, MD, PhD","credentials":["Professor and Division Chief\n","University of Virginia Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Phadia/Thermo-Fisher [IgE treatment (IgE assays)]."},{"name":"Todd M Pollack, MD","credentials":["Assistant Professor in Medicine, Part-time\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Roche Molecular Diagnostics [Initial evaluation of HIV-infected adult (HIV viral load testing)]."},{"name":"Jay M Portnoy, MD","credentials":["Division of Allergy, Asthma and Immunology\n","Children's Mercy Hospitals and Clinics"],"disclosure":"Speaker's Bureau: Thermo Fisher Scientific [IgE testing]; Boehringer Ingelheim [Asthma]."},{"name":"Manuel Praga, MD, PhD","credentials":["Professor of Medicine\n","Complutense University, Madrid"],"disclosure":"Speaker's Bureau: Alexion [Hemolytic uremic syndrome (Eculizumab)]; Otsuka [Polycystic kidney disease (Tolvaptan)]; Fresenius [Hemodialysis]. Consultant/Advisory Boards: Alexion [Hemolytic uremic syndrome (Eculizumab)]; Otsuka [Polycystic kidney disease (Tolvaptan)]; Fresenius [Hemodialysis]."},{"name":"Susan Prescott, MBBS, FRACP, PhD","credentials":["Winthrop Professor and Pediatric Allergist and Immunologist\n","University of Western Australia"],"disclosure":"Grant/Research/Clinical Trial Support: Danone Nutricia [Allergy, early life nutrition, disease prevention (Prebiotic GosFos)]. Speaker's Bureau: Nestle Nutrition [Allergy prevention and early life nutrition (Probiotics)]; Danone Nutricia [Allergy prevention and early life nutrition (Prebiotic GosFos)]. Consultant/Advisory Boards: Nestle Nutrition [Allergy prevention and early life nutrition (Probiotics)]; Danone Nutricia [Allergy prevention and early life nutrition (Prebiotics/Probiotics)]; Bayer [Immune health and disease prevention (Probiotics)]; Swisse Advisory Board [Vitamins and health food supplements (Prebiotics/probiotics)]. Consultant/Advisory Boards (spouse/partner): Genuine Health [Prebiotics, probiotics (Fermented foods)]."},{"name":"Richard W Price, MD","credentials":["Professor Emeritus (Active)\n","Neurology UCSF\n","San Francisco General Hospital"],"disclosure":"Consultant/Advisory Boards: Merck [Single consultant meeting on CNS in HIV (raltegravir)].Other Fiancial Interests: Gilead Sciences, Inc [Honorarium and travel expenses as speaker at a meeting (Tenofovir Alafenanamide and Fumerate, Rilpivarine, Emtriva, Elvitegravir and various combinations of these in single pill doses.)], Merck & Co. [Honorarium and travel expenses as speaker at a meeting (raltegravir)]."},{"name":"Jennifer M Puck, MD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Professor of Pediatrics\n","University of California, San Francisco"],"disclosure":"Consultant/Advisory Boards (spouse): Pfizer [Rare diseases]. Employment (spouse): Invitae [Gene sequencing]. Equity Ownership/Stock Options (spouse): Invitae [Gene sequencing]."},{"name":"Thomas C Quinn, MD","credentials":["Professor of Medicine\n","Johns Hopkins Medical Institute"],"disclosure":""},{"name":"Benjamin A Raby, MD, MPH","credentials":["Section Editor — Genetics\n","Associate Professor of Medicine\n","Harvard Medical School"],"disclosure":"Equity Ownership/Stock Options: CureSpark, Inc [General science]. Employment (spouse): Parexel [Hematology (CRO)] - No relevant conflict on topic."},{"name":"Rima Rachid, MD","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School\n","Boston Children's Hospital"],"disclosure":""},{"name":"Priya Rajendran, MD","credentials":["Clinical Instructor\n","University of California, San Francisco"],"disclosure":""},{"name":"Nima Rezaei, MD, PhD","credentials":["Professor of Clinical Immunology\n","Tehran University of Medical Sciences, Tehran, Iran"],"disclosure":""},{"name":"Nicholas L Rider, DO","credentials":["Associate Professor of Pediatrics, Allergy and Immunology\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Jeffrey Modell Foundation [Primary immunodeficiencies]."},{"name":"William R Robinson, MD","credentials":["Professor of Gynecologic Oncology\n","Tulane Medical School"],"disclosure":""},{"name":"Dario Roccatello, MD","credentials":["Professor of Nephrology and Clinical Pathology\n","University of Turin Medical School"],"disclosure":"Consultant/Advisory Boards: Genzyme [Eliglustat (Gaucher Disease)]."},{"name":"Robin Rockhold, PhD","credentials":["Professor of Pharmacology and Toxicology\n","Associate Professor (Research) of Emergency Medicine\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"Jürgen Kurt Rockstroh, MD","credentials":["Professor of Medicine\n","Department of Medicine I, University of Bonn, Germany"],"disclosure":"Grant/Research/Clinical Trial Support: Abbvie (Hepatitis [Glecaprevir/Pibrentasvir]); Gilead (Hepatitis [Sofosbuvir-ledipasvir]); Merck (Hepatitis [Grazoprevir-elbasvir]). Consultant/Advisory Boards: Abbvie (HIV [Lopinavir/r], hepatitis [Ombitasvir-paritaprevir-ritonavir, dasabuvir, glecaprevir/pibrentasvir]); Gilead (HIV [elvitegravir/c], Hepatitis [Sofosbuvir-ledipasvir, sofosbuvir-velpatasvir]); Janssen (Hepatitis [Simeprevir]); Merck (HIV [Raltegravir], Hepatitis [Grazoprevir-elbasvir]); ViiV (HIV [Dolutegravir])."},{"name":"Diana Rodriguez-Thompson, MD, MPH","credentials":["Clinical Instructor in Obstetrics, Gynecology, and Reproductive Biology\n","Harvard Medical School"],"disclosure":""},{"name":"Chaim M Roifman, MD, FRCPC, FCACB","credentials":["Professor of Pediatrics and Immunology\n","University of Toronto, Canada"],"disclosure":""},{"name":"Antonino Romano, MD","credentials":["Professor of Medicine\n","Catholic University of the Sacred Heart\n","Presidio Columbus, Rome, Italy"],"disclosure":"Consultant/Advisory Boards: Diater SA [Reagents for diagnosis of penicillin allergy (DAP)]."},{"name":"Noel R Rose, MD, PhD","credentials":["Professor of Pathology\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Harold N Rosen, MD","credentials":["Associate Professor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Sergio D Rosenzweig, MD","credentials":["Department of Laboratory Medicine"],"disclosure":""},{"name":"Marc E Rothenberg, MD, PhD","credentials":["Professor of Pediatrics\n","Cincinnati Children's Hospital Medical Center\n","University of Cincinnati College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH; End-Allergies Together; PCORI; CURED Foundation; Adare Pharmaceuticals [Eosinophilic esophagitis (Fluticasone)]. Consultant/Advisory Boards: Immune Pharmaceuticals [Eosinophilic disorders (Bertilimumab)]; PulmOne [Asthma (Laptop PFT equipment)]; Spoon Guru [Food Allergy (Smart phone diet application)]; Celgene [Eosinophilic esophagitis (Anti-IL-13)]; Shire [Eosinophilic esophagitis (Budesonide)]; AstraZeneca [Eosinophilic disorders (Benralizumab)]; GlaxoSmithKline [Eosinophilic disorders (Mepolizumab)]; Adare Pharmaceutical [Eosinophilic esophagitis (Fluticasone)]. Patent Holder: Inventor of patents submitted and owned by CCHMC. Equity Ownership/Stock Options: Immune Pharmaceuticals [Eosinophilic disorders (Bertilibumab)]; NKT Therapeutics [Eosinophilic esophagitis (Anti-NKT cell antibody)]; Spoon Guru [Food allergy (Smart phone diet application)]. Other Financial Interest: Teva Pharmaceuticals [Royalty interest (Reslizumab)]."},{"name":"Florence Roufosse, MD","credentials":["Erasme Hospital, Department of Internal Medicine\n","Universite Libre de Bruxelles, Belgium"],"disclosure":"Consultant/Advisory Boards: GlaxoSmithKline [Hypereosinophilic syndromes (Mepolizumab)]; Knopp Biosciences [Hypereosinophilic syndromes (Dexpramipexole)]."},{"name":"Jean-Claude Roujeau, MD","credentials":["Section Editor — Drug Eruptions\n","Emeritus Professor of Dermatology\n","Université Paris-Est Créteil (UPEC), Créteil, France"],"disclosure":"Consultant/Advisory Boards: AB Science [Mastocytosis (Masitinib)]; SK Biopharmaceuticals [Epilepsy (YKP3089, a new AED in development)]."},{"name":"John M Routes, MD","credentials":["Professor of Pediatrics, Medicine, Microbiology and Molecular Genetics\n","Department of Pediatrics \n","Children's Hospital of Wisconsin \n","Medical College of Wisconsin"],"disclosure":""},{"name":"James L Rubenstein, MD, PhD","credentials":["Professor of Medicine, Division of Hematology/Oncology\n","University of California, San Francisco"],"disclosure":"Grant/Research Support: Celgene [Lymphoma (Lenalidomide)]; Genentech [Lymphoma (Rituximab)]."},{"name":"Arye Rubinstein, MD","credentials":["Professor of Pediatrics Microbiology and Immunology\n","Albert Einstein College of Medicine and Montefiore Hospital Medical Center"],"disclosure":""},{"name":"Kenneth G Saag, MD, MSc","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":"Grant/Research/Clinical Trial Support: Amgen [Osteoporosis]; Ironwood/AstraZeneca [Gout]; Merck [Osteoporosis]; Takeda [Gout]; Horizon [Gout]; SOBI [Gout]. Consultant/Advisory Boards: Ironwood/AstraZeneca [Gout, rheumatoid arthritis]; Takeda [Gout]; Amgen [Osteoporosis, rheumatoid arthritis]; Merck [Osteoporosis, rheumatoid arthritis]; Abbott [Rheumatoid arthritis]; Bristol-Myers Squibb [Rheumatoid arthritis]; Pfizer [Rheumatoid arthritis]; Roche-Genentech [Rheumatoid arthritis]; Bayer [Rheumatoid arthritis]; Horizon [Gout]; Radius [Osteoporosis]; SOBI [Gout]; Lilly [Osteoporosis]."},{"name":"Sarbjit Saini, MD","credentials":["Section Editor — Urticaria and Angioedema\n","Associate Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Asthma, urticaria (Omalizumab)]; AstraZeneca [Asthma, urticaria (Omalizumab)]. Consultant/Advisory Boards: Genentech [Urticaria (Omalizumab)]; Medimmune [Urticaria (Omalizumab)]."},{"name":"Andrew D Samel, MD","credentials":["Affiliate Staff Member\n","Sturdy Memorial Hospital"],"disclosure":""},{"name":"Jonathan M Samet, MD, MS","credentials":["Dean and Professor\n","Colorado School of Public Health"],"disclosure":""},{"name":"Charles V Sanders, MD","credentials":["Edgar Hull Professor and Chair\n","Louisiana State University School of Medicine New Orleans"],"disclosure":"Equity Ownership/Stock Options: Baxter International, Inc."},{"name":"Michael P Savage, MD","credentials":["Ralph J Roberts Professor of Cardiology\n","Thomas Jefferson University"],"disclosure":""},{"name":"Deirdre Sawinski, MD, FAST","credentials":["Assistant Professor of Medicine\n","Assistant Medical Director, Kidney Pancreas Transplantation\n","Renal Electrolyte and Hypertension Division\n","Hospital of the University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Merck [HW treatment (elbasvir-grazoprevir)]."},{"name":"Paul E Sax, MD","credentials":["Section Editor — HIV\n","Clinical Director, Division of Infectious Diseases\n","Brigham and Women's Hospital\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [HIV (tenofovir, emtricitabine, elvitegravir, cobicistat, ledipasvir, sofosbuvir)]; GlaxoSmithKline [HIV (lamivudine, abacavir, dolutegravir)]. Consultant/Advisory Boards: AbbVie [HIV (lopinavir, ritonavir)]; Bristol-Myers Squibb [HIV (atazanavir, efavirenz)]; Gilead Sciences [HIV (tenofovir, emtricitabine, elvitegravir, cobicistat, ledipasvir, sofosbuvir)]; GlaxoSmithKline [HIV (lamivudine, abacavir, dolutegravir)]; Janssen Pharmaceuticals [HIV (darunavir, etravirine, rilpivirine)]; Merck [HIV (raltegravir)]."},{"name":"David T Scadden, MD","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Board: Fate [Stem cells]; Bone Therapeutics [Orthopedics]; FOG Pharma [cancer]; Magenta Therapeutics [stem cells]. Equity Ownership/Stock Options: Fate Therapeutics; Magenta Therapeutic; Clear Creek Bio; Agios Pharmaceuticals."},{"name":"Morris Schambelan, MD","credentials":["Professor Emeritus of Medicine\n","University of California San Francisco"],"disclosure":""},{"name":"Michael Schatz, MD, MS","credentials":["Clinical Professor, Department of Medicine\n","University of California San Diego School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca/Medimmune [Asthma (Benralizumab)]; Merck [Cough]; GlaxoSmithKline [Asthma, (Mepolizumab)]."},{"name":"Rodney J Schlosser, MD","credentials":["Professor and Director of Rhinology and Sinus Surgery\n","Medical University of South Carolina"],"disclosure":"Grant/Research/Clinical Trial Support: Entellus Medical; Intersect ENT; AstraZeneca; Roche; Sanofi; GlaxoSmithKline [Sinus treatments (Possible treatments for nasal polyposis)]. Speaker's Bureau: Olympus; Arrinex; Optinose; Poly-Med [Sinus treatments (Possible treatments for nasal polyposis)]."},{"name":"Peter H Schur, MD","credentials":["Editor-in-Chief — Rheumatology\n","Section Editor — Basic Science\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Lawrence B Schwartz, MD","credentials":["Charles and Evelyn Thomas Professor of Medicine\n","Virginia Commonwealth University"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Hereditary angioedema (C1INH clinical trial)]; Dyax/Shire [Hereditary angioedema (Anti-kallikrein mAb clinical trial)]; Merck (research grant studying desensitization of mast cells by oral immunotherapy); Asthma & Allergy Foundation of America/Sanofi (honorarium to participate in atopic dermatitis in America study). Speaker's Bureau (spouse): Merck (oral immunotherapy); AstraZeneca (anti-IL5R – asthma). Consultant/Advisory Boards: Deciphera [Advisory Board (cKit inhibitor for mastocytosis)]; Genentech [tryptase inhibitor]. Royalties: ThermoFisher/Phadia [tryptase assay]; Millipore, Santa Cruz,  BioLegend, Hycult BioTec [anti-mast cell and –basophil mAbs]; Cecil’s Textbook of Medicine [Anaphylaxis chapter]."},{"name":"Markus G Seidel, MD","credentials":["Professor of Translational Pediatric Hematology and Immunology\n","Medical University of Graz"],"disclosure":"Consultant/Advisory Boards: Shire[Hypogammaglobulinemia (Subcutaneous immunoglobulin, hyaluronic acid)]; Novartis [Thrombocytopenia (TPOR-agonist)]. Other Financial Interest: Novartis [Thrombocytopenia (TPOR-agonist)]; CSL Behring [Hypogammaglobulinemia (Subcutaneous IgG, immune globulin (human))]; Octapharma [Hypogammaglobulinemia (Subcutaneous IgG, immune globulin (human))]."},{"name":"Christine M Seroogy, MD","credentials":["Associate Professor\n","University of Wisconsin Medical School"],"disclosure":""},{"name":"Marc Serota, MD","credentials":["Associate Professor of Dermatology and Allergy\n","Denver VA Medical Center and Denver University"],"disclosure":"Consultant/Advisory Board: Novartis [Dermatology (Secukinumab)]; Sanofi Genzyme [Dermatology (Dupilumab)]; Regeneron [Dermatology (Dupilumab)]; Pfizer [Dermatology (Apremilast)]; Abbvie [Dermatology (Adalimumab)]; Pfizer [Dermatology (Crisaborole)]."},{"name":"Sanjeev Sethi, MD, PhD","credentials":["Professor of Laboratory Medicine and Pathology\n","Mayo Clinic College of Medicine"],"disclosure":""},{"name":"Daniel J Sexton, MD","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor — Bacterial Infections\n","Professor of Medicine\n","Duke University Medical Center"],"disclosure":"Grant/Research/Clinical Trial Support: Centers for Disease Control and Prevention; National Institutes of Health [Healthcare epidemiology]. Consultant/Advisory Boards: Sterilis [Medical waste disposal]; Magnolia Medical Technologies [Medical diagnostics]; National Football League [Infection prevention]; Johnson & Johnson [Mesh-related infections]. Equity Ownership/Stock Options: Magnolia Medical Technologies [Medical diagnostics (Blood culture techniques)]. Other Financial Interest: Johnson & Johnson [Mesh-related infections]."},{"name":"Jo Shapiro, MD","credentials":["Associate Professor of Otology and Laryngology\n","Harvard Medical School"],"disclosure":""},{"name":"James H Shelhamer, MD","credentials":["Deputy Chief, Critical Care Medicine Department, Clinical Center\n","National Institutes of Health"],"disclosure":""},{"name":"Kenneth E Sherman, MD, PhD","credentials":["Professor of Medicine\n","University of Cincinnati College of Medicine"],"disclosure":"Grant/Research Support: AbbVie; BMS; Gilead; Merck; Medimmune; Innovio [HCV, HBV]; Intercept [NASH]. Consultant/Advisory Boards: Merck; Medimmune; Abbot Laboratories [HCV, HBV]; Shionogi [Thrombocytopenia]. Other Financial Interest: MedPace; Watermark DSMBs [NASH, HCV]."},{"name":"Wayne G Shreffler, MD, PhD","credentials":["Massachusetts General Hospital\n","Harvard Medical School"],"disclosure":"Consultant/Advisory Boards: Epiva Biosciences [Food allergy]; Food Allergy Research and Education [Food allergy]; Tunitas Therapeutics [Food allergy]."},{"name":"Scott H Sicherer, MD, FAAAAI","credentials":["Section Editor — Food Allergy\n","Professor of Pediatrics\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: HAL Allergy [Food allergy]; Food Allergy Research and Education [Food allergy]; NIAID [Food allergy clinical trials]. Consultant/Advisory Boards: International Association for FPIES [FPIES]."},{"name":"Ronald C Silvestri, MD","credentials":["Assistant Professor of Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Ronald A Simon, MD","credentials":["Adjunct Professor, Department of Molecular and Experimental Medicine\n","Scripps Research Institute, La Jolla, CA"],"disclosure":""},{"name":"Raymond G Slavin, MD, MS","credentials":["Emeritus Professor of Internal Medicine\n","Saint Louis University School of Medicine"],"disclosure":""},{"name":"John Kelly Smith, MD","credentials":["Fellow and Laureate ACP\n","Emeritus Professor of Medicine\n","James H Quillen College of Medicine\n","East Tennessee State University"],"disclosure":""},{"name":"Scott B Snapper, MD, PhD","credentials":["Associate Professor of Medicine, Harvard Medical School"],"disclosure":""},{"name":"Marianna Sockrider, MD, DrPH","credentials":["Associate Professor of Pediatric Pulmonology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Roland Solensky, MD","credentials":["Lecturer\n","Oregon State University/Oregon Health and Science University College of Pharmacy"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Asthma (Benralizumab)]; Stallergenes Greer [Allergic rhinitis (Grass pollen allergen extract, House dust mite allergen extract)]."},{"name":"Daniel H Solomon, MD, MPH","credentials":["Matthew H. Liang Distinguished Chair in Arthritis and Population Health\n","Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Pfizer [Rheumatoid arthritis (Celecoxib)]."},{"name":"Ricardo U Sorensen, MD","credentials":["Professor Emeritus\n","LSU Health Science Center, New Orleans\n","Honorary Professor\n","Universidad de La Frontera, Temuco, Chile"],"disclosure":""},{"name":"Frederick S Southwick, MD","credentials":["Professor of Medicine\n","University of Florida"],"disclosure":""},{"name":"Jonathan M Spergel, MD, PhD, FAAAAI","credentials":["Professor of Pediatrics\n","University of Pennsylvania School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH; AImmune Therapeutics [Peanut allergy, eosinophilic esophagitis (Peanut powder)]. Consultant/Advisory Boards: Dannone; DBV [Food allergy (Milk and peanut patch)]. Equity Ownership/Stock Options: DBV Technology [Peanut allergy (Milk and peanut patch)]."},{"name":"Timothy R Sterling, MD","credentials":["Professor of Medicine\n","Vanderbilt University School of Medicine"],"disclosure":""},{"name":"Richard H Sterns, MD","credentials":["Editor-in-Chief — Nephrology \n","Section Editor — Fluid and Electrolytes\n","Professor Emeritus\n","University of Rochester School of Medicine and Dentistry"],"disclosure":""},{"name":"E Richard Stiehm, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Immunology and Immunodeficiency\n","Distinguished Research Professor of Pediatrics\n","David Geffen School of Medicine at UCLA"],"disclosure":"Consultant/Advisory Boards: ADMA Biologics [Infections of respiratory syncytial virus in organ transplants (Respiratory syncytial virus immune globulin)]."},{"name":"Jeff Stokes, MD, FAAAAI, FACAAI","credentials":["Professor of Pediatrics\n","Washington University in St. Louis School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH [Asthma (Oral bacterial extracts (ORBEX))]; NIH [Asthma (Allergen immunotherapy (AIT))]."},{"name":"James K Stoller, MD, MS","credentials":["Section Editor — Chronic Obstructive Pulmonary Disease\n","Jean Wall Bennett Professor of Medicine, Samson Global Leadership Academy Endowed Chair\n","Cleveland Clinic Lerner College of Medicine\n","Chairman, Education Institute, Cleveland Clinic"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Alpha-1 antitrypsin detection (Pooled human alpha-1 antiprotease)]. Consultant/Advisory Boards: CSL Behring; Grifols; Shire [Alpha-1 antitrypsin detection (Pooled human alpha-1 antiprotease)]; Arrowhead Pharmaceuticals [Alpha-1 antitrypsin deficiency]."},{"name":"Diane E Stover, MD","credentials":["Editor — Respiratory Infections\n","Chief, Pulmonary Service\n","Memorial Sloan Kettering Cancer Center"],"disclosure":""},{"name":"Scott Stringer, MD","credentials":["Professor of Otolaryngology and Communicative Sciences\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"David L Swanson, MD","credentials":["Associate Professor of Dermatology\n","Mayo Clinic"],"disclosure":""},{"name":"Pablo Tebas, MD","credentials":["Professor of Medicine\n","University of Pennsylvania"],"disclosure":"Consultant/Advisory Boards: Merck [HIV treatment (Raltegravir)], Glaxo [Adjudication Committee (VZV vaccine)]."},{"name":"Elizabeth TePas, MD, MS","credentials":["Senior Deputy Editor — UpToDate\n","Deputy Editor — Allergy and Immunology\n","Deputy Editor — Pediatrics\n","Instructor in Medicine\n","Harvard Medical School"],"disclosure":""},{"name":"Chloe L Thio, MD","credentials":["Professor of Medicine\n","Johns Hopkins University"],"disclosure":"Grant/Research/Clinical Trial Support: Gilead Sciences [Hepatitis (Tenofovir disoproxil fumarate, tenofovir alafenamide)]."},{"name":"Chandler Thompson, DMA, MS, CCC-SLP","credentials":["Speech-Language Pathologist/Professional Voice, Department of Otolaryngology\n","Weill Cornell Medicine, The Sean Parker Institute for the Voice"],"disclosure":""},{"name":"Carey C Thomson, MD, MPH","credentials":["Assistant Professor, \n","Harvard Medical School"],"disclosure":""},{"name":"James M Tracy, DO","credentials":["Assistant Clinical Professor of Internal Medicine\n","Creighton University School of Medicine\n","Associate Clinical Professor of Pediatrics\n","University of Nebraska School of Medicine"],"disclosure":""},{"name":"Glenn J Treisman, MD, PhD","credentials":["Professor of Psychiatry and Behavioral Sciences, Professor of Medicine\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Gulbu Uzel, MD","credentials":["Clinical Investigator\n","National Institute of Allergy and Infectious Diseases\n","National Institutes of Health"],"disclosure":""},{"name":"Carlos A Vaz Fragoso, MD","credentials":["Associate Professor in Medicine (Geriatrics)\n","Yale University School of Medicine"],"disclosure":""},{"name":"John Vella, MD, FACP, FRCP, FASN, FAST","credentials":["Associate Professor of Medicine\n","Tufts University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Astellas; Bristol Myers Squibb [Transplantation (CMV vaccine, belatacept)]."},{"name":"James Verbsky, MD, PhD","credentials":["Associate Professor of Pediatrics and Microbiology and Molecular Genetics\n","Medical College of Wisconsin"],"disclosure":""},{"name":"Richard S Vetter, MS","credentials":["Department of Entomology\n","University of California, Riverside"],"disclosure":""},{"name":"Sebastien Viatte, MD, PhD","credentials":["Lecturer in Genetics\n","Arthritis Research UK Centre for Genetics and Genomics\n","The University of Manchester, UK"],"disclosure":""},{"name":"Anna Wald, MD, MPH","credentials":["Professor of Medicine, Epidemiology, and Laboratory Medicine\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Genocea [Herpes simplex virus (HSV therapeutic vaccine)]; Vical [Herpes simplex virus (HSV therapeutic vaccine)]. Consultant/Advisory Boards: AiCuris [Herpes simplex virus (novel antiviral for HSV)]; GSK [Herpes simplex virus (therapeutic HSV vaccine)]; Merck DSMB [Varicella zoster virus (HSV therapeutic vaccine)]."},{"name":"Julie Wang, MD","credentials":["Associate Professor of Pediatrics\n","Icahn School of Medicine at Mount Sinai"],"disclosure":"Grant/Research/Clinical Trial Support: Aimmune [Food allergy (Investigational oral immunotherapy product for peanut); DBV Technologies [Food allergy (Investigational epicutaneous immunotherapy product for peanut)]. Consultant/Advisory Boards: Aimmune [Food allergy (Investigational oral immunotherapy product for peanut)]; JDP Therapeutics [Food allergy]; DBV Technologies [Food allergy (Investigational epicutaneous immunotherapy product for peanut)]. Other Financial Interest (DMC member): ALK [Allergen extracts]."},{"name":"Marilene B Wang, MD","credentials":["Professor, Division of Head and Neck Surgery\n","David Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"David J Weber, MD, MPH","credentials":["Professor of Medicine, Pediatrics and Epidemiology\n","University of North Carolina Schools of Medicine and Public Health"],"disclosure":"Grant/Research/Clinical Trial Support: CDC [Infection control]. Speaker's Bureau: Merck [Vaccines (Varicella and hepatitis B vaccine)]; Pfizer [Vaccines]. Consultant/Advisory Boards: Merck [Vaccines (Varicella and hepatitis B vaccine)]; Pfizer [Vaccines]; Germitec [Vaccines]; PDI [Disinfection products]; Germitec [Disinfection device]."},{"name":"Melissa Weinberg, MD","credentials":["Assistant Clinical Professor of Medicine\n","University of California, San Francisco"],"disclosure":""},{"name":"Miles Weinberger, MD","credentials":["Professor Emeritus\n","University of Iowa"],"disclosure":""},{"name":"Steven E Weinberger, MD","credentials":["Adjunct Professor of Medicine\n","University of Pennsylvania School of Medicine\n","Executive Vice President and CEO Emeritus\n","American College of Physicians"],"disclosure":""},{"name":"Scott T Weiss, MD, MS","credentials":["Professor of Medicine\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Asthma (Omalizamab [Anti IgE])]."},{"name":"Peter F Weller, MD, MACP","credentials":["Editor-in-Chief — Infectious Diseases\n","Section Editor — Tropical Medicine\n","William Bosworth Castle Professor of Medicine\n","Harvard Medical School\n","Professor of Immunology and Infectious Diseases\n","Harvard T. H. Chan School of Public Health"],"disclosure":"Grant/Research/Clinical Trial Support: GlaxoSmithKline [Anti-IL5 mAb for EGPA (Mepolizumab)]."},{"name":"Mark H Wener, MD","credentials":["Section Editor — Diagnostic Issues in Rheumatology\n","Professor of Laboratory Medicine and Medicine/Rheumatology\n","University of Washington"],"disclosure":"Grant/Research/Clinical Trial Support: Boehringer-Ingelheim [Scleroderma (Nintedanib)]; Medical Training Software [Production of laboratory training and competency assessment software (Autoimmune Tutor)]; BioRad [Reference lab testing for ANA patterns (ANA substrate, autoimmune diagnostics)]. Other Financial Interest: Rheumatology (Oxford) [Associate Editor (Medical journal)]."},{"name":"Sally Wenzel, MD","credentials":["Professor of Medicine\n","University of Pittsburgh"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Asthma (Benralizumab]; GSK [Asthma (Mepolizumab)]; Novartis [Asthma (Fevipiprant)]; Sanofi Aventis [Asthma (Dupliumab)]; Boehringer-Ingelheim [Asthma (IL-23 antibody)]. Consultant/Advisory Boards: AstraZeneca [Asthma (Benralizumab)]; Boehringer-Ingelheim [Asthma (CRTH2 antagonists)]; Novartis [Asthma (Fevipiprant)]; Sanofi-Regeneron [Asthma (Dupilumab); Avirigen [Anti RV drug]; Genentech [General asthma]."},{"name":"Christina West, MD, PhD","credentials":["Department of Clinical Sciences\n","Pediatrics Umeå University, Sweden"],"disclosure":"Speaker's Bureau: HiPP [Probiotics]; Nutricia/Danone (Pre- and probiotics); Wyeth Nutrition (Prebiotics)."},{"name":"William L Weston, MD","credentials":["Professor Emeritus of Dermatology\n","University of Colorado Denver School of Medicine"],"disclosure":""},{"name":"Julian White, AM, MB, BS, MD, FACTM","credentials":["Professor\n","The University of Adelaide"],"disclosure":"Consultant: Seqirus (management of envenoming/use of antivenom). Dr. White receives travel support to attend academic meetings in his role as clinical toxinology consultant for Seqirus Ltd, but no direct income from Seqirus, the sole producer of antivenoms for human use in Australia."},{"name":"C Mel Wilcox, MD","credentials":["Professor of Medicine\n","University of Alabama at Birmingham"],"disclosure":""},{"name":"David F Williams, PhD","credentials":["Courtesy Professor of Entomology and Nematology\n","University of Florida (Gainesville)"],"disclosure":""},{"name":"Nevin W Wilson, MD","credentials":["Professor and Chairman of Pediatrics\n","University of Nevada, Las Vegas School of Medicine"],"disclosure":""},{"name":"Cameron Wolfe, MBBS (Hons)","credentials":["Director Biopreparedness \n","Duke Preparedness & Response Center \n","Division of Infectious Diseases \n","Duke University"],"disclosure":"Grant/Research/Clinical Trial Support: Merck [HIV].  Consultant/Advisory Boards: Astellas [Antifungal development (Isavuconazole)]."},{"name":"Brian R Wood, MD","credentials":["Associate Professor of Medicine\n","University of Washington Division of Allergy and Infectious Disease"],"disclosure":""},{"name":"Robert A Wood, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Pediatric Allergy\n","Professor of Pediatrics\n","Johns Hopkins University School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: DBV Technologies; Aimmune; Astellas; HAL-Allergy [Food allergy]."},{"name":"Eveline Wu, MD","credentials":["Assistant Professor of Pediatrics\n","University of North Carolina at Chapel Hill"],"disclosure":""},{"name":"Christina M Wyatt, MD","credentials":["Associate Professor\n","Icahn School of Medicine at Mount Sinai"],"disclosure":""},{"name":"David L Wyles, MD","credentials":["Associate Professor of Medicine\n","Denver Health"],"disclosure":"Grant/Research/Clinical Trial Support: AbbVie [HCV (paritaprevir/r/ombitasvir+dasabuvir)]; BMS [HCV (daclatasvir, asunaprevir, 325)]; Gilead [HCV (sofosbuvir, ledipasvir, velpatasvir)]; Merck [HCV (grazoprevir, elbasvir)]; Tacere [HCV (TT-034)]. Consultant/Advisory Boards: AbbVie [HCV (paritaprevir/r/ombitasvir+dasabuvir)]; BMS [HCV (daclatasvir, asunaprevir, 325)]; Gilead [HCV (sofosbuvir, ledipasvir, velpatasvir)]; Merck [HCV (grazoprevir, elbasvir)]."},{"name":"Leman Yel, MD","credentials":["Associate Professor Emeritus of Clinical Medicine\n","University of California"],"disclosure":"Employment: Shire Plc [Immunology] - No relevant conflict on topic. Equity Ownership/Stock Options: Shire Plc."},{"name":"Lisa R Young, MD","credentials":["Associate Professor of Pediatrics and Medicine\n","Vanderbilt University School of Medicine"],"disclosure":""},{"name":"Atefeh Zeinoddini, MD","credentials":["Research Fellow at Research Center for Immunodeficiencies\n","Tehran University of Medical Sciences"],"disclosure":""},{"name":"Bruce Zuraw, MD","credentials":["Professor of Medicine\n","University of California San Diego"],"disclosure":"Consultant/Advisory Boards: Shire [Hereditary angioedema (Icatibant, ecallantide, pdC1INH-nf)]; CSL Behring [Hereditary angioedema (pdC1INH-nf)]; BioCryst [Hereditary angioedema]; Novartis [Allergy]; Genentech [Allergy]. Consultant/Advisory Boards (Spouse): Shire [Hereditary angioedema (Icatibant, ecallantide, pdC1INH-nf)]; CSL Behring [Hereditary angioedema (pdC1INH-nf)]."}]},{"name":"Peer Reviewers","contributors":[{"name":"Seema S Aceves, MD, PhD","credentials":["Associate Professor of Pediatrics and Medicine\n","University of California, San Diego\n","Rady Children's Hospital, San Diiego"],"disclosure":"Grant/Research/Clinical Trial Support: Ferring Research Institute [Eosinophilic esophagitis]. Consultant/Advisory Boards: Regeneron Pharma [Eosinophilic esophagitis (Dupilumab)]. Patent Holder: UCSD [Oral viscous budesonide licensed by Shire]."},{"name":"Chester Alper, MD","credentials":["Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Carlos A Bacino, MD, FACMG","credentials":["Professor of Molecular and Human Genetics\n","Baylor College of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: BioMarin [Achondroplasia phase-II clinical trial (Vosoritide)]. Speaker's Bureau: Alexion Pharmaceuticals [Diagnosis and management of hypophophatasia]."},{"name":"Mark Ballow, MD","credentials":["Professor of Pediatrics\n","All Children’s Hospital\n","University of South Florida School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial (Immunoglobulin)]; Shire [Immunoglobulin trial (Immunoglobulin)]. Speaker's Bureau: Shire [Immunodeficiency (Immunoglobulin)]; Grifols [Immunoglobulin trial (Immunoglobulin)]. Consultant/Advisory Boards: Grifols [Immunodeficiency (Immunoglobulin)]; CSL Behring [Immunodeficiency (Immunoglobulin)]; Shire [Immunodeficiency (Immunoglobulin)]. Other Financial Interest (Data Safety Monitoring Boards): Prometic; CSL Behring; Green Cross [Immunoglobulin]."},{"name":"Edward M Behrens, MD","credentials":["Assistant Professor of Pediatrics\n","University of Pennsylvania School of Medicine"],"disclosure":""},{"name":"Jonathan A Bernstein, MD","credentials":["Professor of Medicine\n","University of Cincinnati College of Medicine"],"disclosure":""},{"name":"Michael S Blaiss, MD","credentials":["Clinical Professor of Pediatrics\n","Medical College of Georgia at Augusta University"],"disclosure":"Consultant/Advisory Boards: Stallergenes Greer [Allergen immunotherapy]; Pfizer [Over-the-counter allergy and cold medications]; ALK [Allergen immunotherapy]; Boston Scientific [Asthma treatment]; Bayer [Over-the-counter allergy treatments]; PMD Healthcare [Spirometry]."},{"name":"Bruce S Bochner, MD","credentials":["Editor-in-Chief — Allergy and Immunology\n","Section Editor — Adult Allergy; Asthma\n","Samuel M Feinberg Professor of Medicine \n","Northwestern University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIAID; NHLBI, Acerta Pharma [Siglec-6, Siglec-8, Siglec-9, asthma, COPD, anaphylaxis, imaging, eosinophilic granulomatosis with polyangiitis, food allergy, Bruton's tyrosine kinase, mastocytosis]. Consultant/Advisory Boards: GSK; AstraZeneca; TEVA; Genentech; Allakos [Eosinophil and mast cell-related disease (Mepolizumab, reslizumab, benralizumab)]. Patent Holder: Siglec-8 and its ligand; anti-Siglec-8 antibodies [Eosinophil and mast cell-associated disease (AK002 [in clinical trials; not yet FDA-approved])]. Equity Ownership/Stock Options: Allakos [Eosinophil and mast cell-associated diseases (AK002 [in clinical trials; not yet FDA-approved])]. Other Financial Interest: Elsevier [Publication royalties (Allergy and Immunology)]."},{"name":"David Broide, MBChB","credentials":["Professor of Medicine\n","University of California San Diego"],"disclosure":""},{"name":"Rebecca H Buckley, MD","credentials":["Professor of Pediatrics and Immunology\n","Duke University School of Medicine"],"disclosure":""},{"name":"Robert Bush, MD","credentials":["Professor Emeritus of Medicine\n","University of Wisconsin, Madison"],"disclosure":"Other Financial Interest: Associate Editor for the Journal of Allergy and Clinical Immunology; Section Editor for Current Allergy and Asthma Reports; Section Editor for Current Opinions in Allergy and Immunology."},{"name":"Ronna L Campbell, MD, PhD","credentials":["Associate Professor of Emergency Medicine\n","Mayo Clinic"],"disclosure":"Consultant/Advisory Boards: INSYS Therapeutics [Anaphylaxis]."},{"name":"Melody C Carter, MD","credentials":["Staff Clinician\n","National Institutes of Health"],"disclosure":""},{"name":"Talal Chatila, MD","credentials":["Denise and David Bunning Professor of Pediatrics\n","Harvard Medical School\n","The Boston Children's Hospital"],"disclosure":""},{"name":"Bradley E Chipps, MD","credentials":["Capital Allergy & Respiratory Disease Center"],"disclosure":"Speaker's Bureau: AstraZeneca [Asthma/COPD (Budesonide and formoterol)]; Boehringer Ingelheim [Asthma/COPD (Tiotropium)]; Circassia [Severe asthma (NIOX, FeNO)]; Genentech [Evolving Science of ASthma (Omalizumab)]; Novartis [Asthma (Omalizumab)]; Teva [Eosinophilic asthma (Reslizumab)]. Consultant/Advisory Boards: AstraZeneca [Asthma/COPD (Budesonide and formoterol)]; Boehringer Ingelheim [Asthma/COPD (Tiotropium)]; Circassia [Severe asthma (NIOX, FeNO)]; Genentech [Evolving Science of ASthma (Omalizumab)]; Novartis [Asthma (Omalizumab)]; Teva [Eosinophilic asthma (Reslizumab)]."},{"name":"Timothy Craig, MD","credentials":["Professor of Medicine and Pediatrics\n","Pennsylvania State University"],"disclosure":"Grant/Research/Clinical Trial Support: Shire; Biocryst; CSL Behring [Hereditary angioedema (alpha-1-antitrypsin)]. Speaker's Bureau: CSL Behring; Grifols [Hereditary angioedema and alpha-1-deficiency (Ecallantide, C1-inhibitors, icatibant, alpha1-protein)]. Consultant/Advisory Boards: Biocryst; CSL Behring; Shire [Hereditary angioedema (Research drug)]."},{"name":"Jason Debley, MD, MPH","credentials":["Associate Professor, Pediatrics, Division of Pulmonary Medicine\n","Seattle Children's Hospital, University of Washington School of Medicine"],"disclosure":""},{"name":"Richard D deShazo, MD","credentials":["Billy S Guyton Distinguished Professor\n","Professor of Medicine and Pediatrics\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"Damon Eisen, MBBS, MD, FRACP","credentials":["Professor of Medicine, Townsville\n","College of Medicine and Dentistry, James Cook University\n","Director of Clinical Research, Infectious Diseases Physician\n","Townsville Hospital and Health Service"],"disclosure":""},{"name":"Alejandro Escobar-Gutiérrez, PhD","credentials":["Department for Immunology Research\n","Institute of Epidemiological Diagnosis and Reference\n","Health Secretariat\n","Mexico City, Mexico"],"disclosure":""},{"name":"Henry M Feder, MD","credentials":["Professor of Pediatrics and Family Medicine\n","University of Connecticut Health Center"],"disclosure":""},{"name":"Theodore Freeman, MD","credentials":["San Antonio Asthma and Allergy Clinic"],"disclosure":""},{"name":"Robert C Fuhlbrigge, MD, PhD","credentials":["Professor of Pediatrics\n","University of Colorado School of Medicine"],"disclosure":""},{"name":"Maria I Garcia-Lloret, MD, MS","credentials":["Associate Professor of Pediatrics\n","David Geffen School of Medicine at UCLA"],"disclosure":""},{"name":"Lene Heise Garvey, MD, PhD","credentials":["Specialist in Anesthesiology, Subspecialist in Allergology\n","Copenhagen University Hospital Gentofte, Denmark"],"disclosure":""},{"name":"Andrew Gennery, MD","credentials":["Clinical Reader/Consultant\n","Newcastle University"],"disclosure":""},{"name":"Paul Allen Greenberger, MD","credentials":["Professor of Medicine\n","Northwestern University Feinberg School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: Immune Tolerance Network; NIAID; Amgen [Allergic rhinitis]. Consultant/Advisory Boards: Allergy Therapeutics [Allergic rhinitis]."},{"name":"Bodo Grimbacher, MD","credentials":["Centre of Chronic Immunodeficiency\n","University Medical Centre Freiburg"],"disclosure":"Grant/Research/Clinical Trial Support:BMBF; EU; Helmholtz; DFG; DLR; DZIF, Novartis; CSL Behring, Biotest, Bristol-Myers-Squibb, Baxalta/Shire [Immunodeficiency research (Human immunoglobulin)]. Speaker's Bureau: CSL Behring; Baxalta/Shire; Biotest [Immunodeficiencies (Human immunoglobulin)]."},{"name":"Alexei A Grom, MD","credentials":["Professor of Pediatrics\n","Cincinnati Children’s Hospital Medical Center, Division of Rheumatology"],"disclosure":"Grant/Research/Clinical Trial Support: NovImmune [Macrophage activation syndrome and hemophagocytic lymphohistiocytosis)]. Speaker's Bureau: Novartis [Systemic juvenile idiopathic arthritis (Canakinumab)]. Consultant/Advisory Boards: Novartis [Macrophage activation syndrome and systemic juvenile idiopathic arthritis (Canakinumab)]; Ab2Bio [Macrophage activation syndrome and systemic juvenile idiopathic arthritis (IL18BP)]."},{"name":"Gary N Gross, MD","credentials":["Clinical Professor Internal Medicine\n","University of Texas Southwestern Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Stallergens [Allergic rhinitis (Sublingual tablets)]. Speaker's Bureau: ALK [Allergy rhinitis (Sublingual tablets)]."},{"name":"Sudhir Gupta, MD, PhD, MACP","credentials":["Professor of Medicine, Pathology & Laboratory Medicine, and Microbiology & Molecular Genetics \n","Chief, Basic and Clinical Immunology \n","University of California, Irvine"],"disclosure":"Grant/Research/Clinical Trial Support: Baxalta/Shire [Investigator research grant]; Octapharma; ProMetic; BPL."},{"name":"Kathleen M Gura, PharmD, BCNSP, FASHP","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":"Grant/Research/Clinical Trial Support: Fresenius Kabi [Parenteral nutrition-associated liver disease (Intravenous lipid emulsions)]; ProNova/BASF [Omega-3 fatty acids (Fish oil)]; Sancilio & Company [Omega-3 fatty acids (Fish oil)]. Consultant/Advisory Boards: Sancilio & Company [Omegaven-3 fatty acids (Fish oil)]; B Braun [Pharmacy/Parenteral nutrition compounding (Intravenous lipid emulsions)]; ProNova/BASF [Omega-3 fatty acids (Fish oil)]. Patent Holder: [Liver disease associated with parenteral nutrition (Omegaven)]. Other Financial Interest: Licensing agreement - Boston Children’s Hospital and Fresenius Kabi [Parenteral nutrition-associated liver disease (Intravenous fish oil)]."},{"name":"Robert G Hamilton, PhD, DABMLI, FAAAAI","credentials":["Professor of Medicine and Pathology\n","Johns Hopkins University School of Medicine"],"disclosure":""},{"name":"Derralynn Hughes, MD","credentials":["Senior Lecturer Honorary Consultant\n","University College London\n","Royal Free London"],"disclosure":"Grant/Research/Clinical Trial Support: Shire [Gaucher disease (Imiglucerase); Genzyme [Gaucher disease (Velaglucerase)]. Grant/Research/Clinical Trial Support (spouse): Shire [Gaucher disease (Imiglucerase)]. Speaker's Bureau: Shire [Gaucher disease (Imiglucerase)]l Genzyme [Gaucher disease (Velaglucerase)]. Speak'er's Bureau (spouse): Shire [Gaucher disease (Imiglucerase)]. Consultant/Advisory Boards: Shire [Gaucher disease (Imiglucerase)]; Genzyme [Gaucher disease (Velaglucerase)]; Protalix [Gaucher disease (Taliglucerase)]; Actelion [Gaucher disease (Miglustat)]. Consultant/Advisory Boards (spouse): Shire [Gaucher disease (Imiglucerase)]."},{"name":"Allen P Kaplan, MD","credentials":["Clinical Professor\n","Medical University of South Carolina"],"disclosure":"Consultant/Advisory Boards: Sanofi-Aventis [Allergic reactions]; Genentech [Angioedema]."},{"name":"Corinne Keet, MD, PhD","credentials":["Assistant Professor of Pediatrics\n","Johns Hopkins School of Medicine"],"disclosure":""},{"name":"John M Kelso, MD","credentials":["Section Editor – Anaphylaxis\n","Division of Allergy, Asthma, and Immunology\n","Scripps Clinic, San Diego, CA"],"disclosure":""},{"name":"Stephen F Kemp, MD","credentials":["Professor of Medicine and Pediatrics\n","University of Mississippi Medical Center"],"disclosure":""},{"name":"Carolyn M Kercsmar, MD","credentials":["Professor of Pediatrics\n","University of Cincinnati School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: GSK [Asthma (Mepolizumab)]"},{"name":"David A Khan, MD","credentials":["Professor of Medicine and Pediatrics\n","UT Southwestern Medical Center"],"disclosure":"Speaker's Bureau: Genentech [Urticaria (Omalizumab)]. Consultant/Advisory Boards: Aimmune [Food allergy]."},{"name":"Marek L Kowalski, MD, PhD","credentials":["Professor of Medicine \n","Medical University of Lodz, Poland"],"disclosure":""},{"name":"Richard D Kramer, PhD","credentials":["Entomologist, President\n","Innovative Pest Management"],"disclosure":""},{"name":"Deidre R Larrier, MD","credentials":["Assistant Professor of Pediatric Otolaryngology\n","Baylor College of Medicine"],"disclosure":""},{"name":"Jerrold H Levy, MD, FAHA, FCCM","credentials":["Professor of Anesthesiology\n","Associate Professor of Surgery\n","Co-Director, Cardiothoracic ICU\n","Duke University Hospital"],"disclosure":""},{"name":"H Henry Li, MD, PhD, CPI","credentials":["Director of Immunology\n","Institute for Asthma and Allergy"],"disclosure":"Grant/Research/Clinical Trial Support: Shire; Viropharma; Dyax; Biocryst; CSL Behring; Pharming; Salix [Hereditary angioedema (C1 esterase inhibitor [human], C1 esterase inhibitor [recombinant], icatibant injection, ecallantide)]. Speaker's Bureau: Shire; CSL Behring [Hereditary angioedema (C1 esterase inhibitor [human], icanibant injection, ecallantide)]. Consultant/Advisory Boards: Shire; US Hereditary Angioedema Association; Pharming; Salix; CSL Behring [Hereditary angioedema (C1 esterase inhibitor [human], C1 esterase inhibitor [recombinant], icatibant injection, ecallantide]. Employment: Institute for Asthma and Allergy [Allergy (clinic)]."},{"name":"Phillip L Lieberman, MD","credentials":["Clinical Professor of Medicine and Pediatrics\n","University of Tennessee College of Medicine"],"disclosure":"Speaker's Bureau: MYLAN [Rhinitis (Azelastine/fluticasone nasal spray)]; TEVA [Rhinitis (Beclomethasone)]."},{"name":"Nirupama Madduri, MD","credentials":["Assistant Professor of Pediatrics\n","University of Southern California Keck School of Medicine"],"disclosure":""},{"name":"Stephen McGeady, MD","credentials":["Professor of Pediatrics\n","Sidney Kimmel Medical College, Thomas Jefferson University\n","Attending Physician\n","AI DuPont Hospital for Children"],"disclosure":""},{"name":"J Lawrence Merritt II, MD","credentials":["Associate Professor\n","University of Washington School of Medicine, Seattle Children's Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Genzyme [Gaucher disease, Pompe disease (Imiglucerase, Alglucosidase alfa)]. Consultant/Advisory Boards: Synlogic, Inc (inborn errors of metabolism)."},{"name":"Michael D Nelson, MD, PhD","credentials":["Virginia S. Lang Professor and Vice Chairman of Obstetrics and Gynecology\n","Washington University School of Medicine"],"disclosure":""},{"name":"Tim Niehues, MD","credentials":["Professor of Pediatrics\n","HELIOS Klinikum Krefeld\n","Academic Hospital, RWTH Aachen University"],"disclosure":""},{"name":"Luigi D Notarangelo, MD","credentials":["Section Editor — Immunology and Immunodeficiency\n","Bethesda, MD"],"disclosure":""},{"name":"John Oppenheimer, MD","credentials":["Professor of Medicine \n","University of Medicine and Dentistry of New Jersey-Rutgers"],"disclosure":"Grant/Research/Clinical Trial Support: Novartis [Asthma (Omalizumab)]; Medimmune [Asthma (Benralizumab and Tralokinumab)]; Teva [Asthma (Reslizumab)]. Consultant/Advisory Boards: Kaleo[Anaphylaxis]; GlaxoSmithKline [Asthma]; AZ [Asthma]; Sanofi [Asthma]; DBV [Food allergy]. Other Financial Interest: Annals of Allergy, AllergyWatch [Associate Editor]; Medscape [Associate Editor - Pulmonary]."},{"name":"Elena E Perez, MD, PhD","credentials":["Associate\n","Allergy Associates of the Palm Beaches"],"disclosure":"Speaker's Bureau: CSL Behring [Immunology (Intravenous immune globulin)]. Consultant/Advisory Boards: CSL Behring [Immunology (Intravenous immune globulin)]; Shire [Immunology (Intravenous immune globulin)]; Grifols [Immunology (Intravenous immune globulin)]."},{"name":"Elizabeth J Phillips, MD, FRCPC, FRACP, FIDSA, FAAAAI","credentials":["Professor of Medicine & Pharmacology\n","John A. Oates Chair in Clinical Research\n","Vanderbilt University Medical Center\n","Institute for Immunology & Infectious Diseases"],"disclosure":""},{"name":"Jay M Portnoy, MD","credentials":["Division of Allergy, Asthma and Immunology\n","Children's Mercy Hospitals and Clinics"],"disclosure":"Speaker's Bureau: Thermo Fisher Scientific [IgE testing]; Boehringer Ingelheim [Asthma]."},{"name":"Lisa Prock, MD, MPH","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Nima Rezaei, MD, PhD","credentials":["Professor of Clinical Immunology\n","Tehran University of Medical Sciences, Tehran, Iran"],"disclosure":""},{"name":"Chaim M Roifman, MD, FRCPC, FCACB","credentials":["Professor of Pediatrics and Immunology\n","University of Toronto, Canada"],"disclosure":""},{"name":"Lanny J Rosenwasser, MD","credentials":["Professor of Medicine\n","University of Missouri-Kansas City School of Medicine"],"disclosure":""},{"name":"Kelly A Rouster-Stevens, MD, MS","credentials":["Assistant Professor of Pediatrics\n","Emory University School of Medicine"],"disclosure":""},{"name":"Anne Rowley, MD","credentials":["Professor of Pediatrics and of Microbiology and Immunology\n","Northwestern University Feinberg School of Medicine"],"disclosure":""},{"name":"Lawrence B Schwartz, MD","credentials":["Charles and Evelyn Thomas Professor of Medicine\n","Virginia Commonwealth University"],"disclosure":"Grant/Research/Clinical Trial Support: CSL Behring [Hereditary angioedema (C1INH clinical trial)]; Dyax/Shire [Hereditary angioedema (Anti-kallikrein mAb clinical trial)]; Merck (research grant studying desensitization of mast cells by oral immunotherapy); Asthma & Allergy Foundation of America/Sanofi (honorarium to participate in atopic dermatitis in America study). Speaker's Bureau (spouse): Merck (oral immunotherapy); AstraZeneca (anti-IL5R – asthma). Consultant/Advisory Boards: Deciphera [Advisory Board (cKit inhibitor for mastocytosis)]; Genentech [tryptase inhibitor]. Royalties: ThermoFisher/Phadia [tryptase assay]; Millipore, Santa Cruz,  BioLegend, Hycult BioTec [anti-mast cell and –basophil mAbs]; Cecil’s Textbook of Medicine [Anaphylaxis chapter]."},{"name":"Reinhard Seger, MD","credentials":["Professor Emeritus of Pediatric Immunology/BMT\n","University Children's Hospital\n","Zürich, Switzerland"],"disclosure":""},{"name":"Irini Sereti, MD, MHS","credentials":["ID physician\n","Washington, DC"],"disclosure":""},{"name":"Roland Solensky, MD","credentials":["Lecturer\n","Oregon State University/Oregon Health and Science University College of Pharmacy"],"disclosure":"Grant/Research/Clinical Trial Support: AstraZeneca [Asthma (Benralizumab)]; Stallergenes Greer [Allergic rhinitis (Grass pollen allergen extract, House dust mite allergen extract)]."},{"name":"Mary Beth F Son, MD","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Jonathan M Spergel, MD, PhD, FAAAAI","credentials":["Professor of Pediatrics\n","University of Pennsylvania School of Medicine"],"disclosure":"Grant/Research/Clinical Trial Support: NIH; AImmune Therapeutics [Peanut allergy, eosinophilic esophagitis (Peanut powder)]. Consultant/Advisory Boards: Dannone; DBV [Food allergy (Milk and peanut patch)]. Equity Ownership/Stock Options: DBV Technology [Peanut allergy (Milk and peanut patch)]."},{"name":"Joan M Stoler, MD","credentials":["Assistant Professor of Pediatrics\n","Harvard Medical School"],"disclosure":""},{"name":"Alan Sugar, MD","credentials":["Professor and Vice Chair, Ophthalmology and Visual Sciences\n","WK Kellogg Eye Center\n","University of Michigan Medical School"],"disclosure":""},{"name":"Kathleen Sullivan, MD, PhD","credentials":["Professor of Pediatrics\n","Children's Hospital of Philadelphia"],"disclosure":"Consultant/Advisory Board: Immune deficiency foundation [Immune deficiency]. Other Financial Interest (Royalties): Elsevier [Textbook]."},{"name":"Angela Sun, MD","credentials":["Assistant Professor of Pediatrics\n","University of Washington School of Medicine\n","Seattle Children's Hospital"],"disclosure":""},{"name":"Troy R Torgerson, MD, PhD","credentials":["Associate Professor of Pediatrics\n","University of Washington\n","Seattle Children's Hospital"],"disclosure":"Grant/Research/Clinical Trial Support: Baxter Biosciences [Immunodeficiency diagnostics (IVIG/SCIG)]; CSL Behring [Immunodeficiency diagnostics (IVIG/SCIG)]. Consultant/Advisory Boards: Baxalta, CSL Behring, ADMA Biosciences [Immunodeficiency (IVIG/SCIG)]."},{"name":"James Verbsky, MD, PhD","credentials":["Associate Professor of Pediatrics and Microbiology and Molecular Genetics\n","Medical College of Wisconsin"],"disclosure":""},{"name":"Michael E Weiss, MD","credentials":["Clinical Professor of Medicine\n","University of Washington, School of Medicine\n","Northwest Asthma & Allergy Center"],"disclosure":""},{"name":"Pamela F Weiss, MD, MSCE","credentials":["Associate Professor\n","Departments of Pediatrics and Epidemiology\n","Perelman School of Medicine, University of Pennsylvania\n","Division of Rheumatology, Children's Hospital of Philadelphia"],"disclosure":"Grant/Research Clinical Trial Support: PCORI [Polyarticular JIA comparative effectiveness]; Arthritis Foundation [Polyarticular JIA]. Consultant/Advisory Boards: Lilly [Arthritis (Baricitinib and ixekizumab)]."},{"name":"Michael J Welch, MD, FAAAAI","credentials":["Clinical Professor\n","University of California, San Diego School of Medicine"],"disclosure":""},{"name":"Kevin L Winthrop, MD, MPH","credentials":["Professor, School of Public Health\n","Associate Professor, Department of Medicine\n","Divisions of Infectious Disease and Ophthalmology, \n","Oregon Health and Sciences University"],"disclosure":"Grant/Research/Clinical Trial Support: Bristol-Myers Squibb [vaccine]. Consultant/Advisory Boards: Pfizer [Rheumatology (Tofacitinib, etanercept)]; UCB [Rheumatology (Certolizumab); Amgen, Abbvie [Rheumatology (Adalimumab)]."},{"name":"Robert S Zeiger, MD, PhD","credentials":["Clinical Professor of Pediatrics \n","University of California, San Diego"],"disclosure":"Consultant/Advisory Boards: DBV Technologies [Food allergy (Epicutaneous immunotherapy)]. Equity Ownership/Stock Options: DBV Technologies [Food allergy (Epicutaneous immunotherapy)]."}]}]}